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Abstract
Within living cells, biomolecules rarely function as isolated elements, but rather interact with each other
to perform various biological functions. Biomolecules and their interactions can be represented as biomolec-
ular networks, in which nodes represent different biomolecules and edges represent interactions among
biomolecules. The studies of biomolecular networks are critical for understanding the roles of biomolecules
within cells and the mechanisms of cellular behaviors. Due to the interactions among biomolecules, the
perturbation of some biomolecules may affect others which may eventually change the states of biomolecular
networks and corresponding cellular behaviors. Therefore, it is essential and helpful to study biomolecular
networks from the viewpoint of control theory.
This thesis investigates the controllability of biomolecular networks based on modern control theory,
especially the structural controllability of complex networks. Controllability, which is an important concept
in modern control theory, measures the ability of moving a network around in its state space via proper
input control signals. To control a complex network, the first step is to identify steering nodes that guarantee
the controllability of the network, where steering nodes are nodes directly actuated by input control signals.
Although various algorithms have been proposed to identify steering nodes for general complex networks,
the applications of the algorithms to biomolecular networks are limited and still have room to be further
improved. This thesis focuses on identifying steering nodes, which are biomolecules, for different control
scenarios in biomolecular networks.
Three different control scenarios are considered in this thesis. First, to control a network, it’s meaningful
to determine the least number of nodes which should be actuated by input control signals. To deal with
this problem, an algorithm to identify the minimum steering node sets (MSSs) required to have complex
networks completely controllable is presented and its applications to biomolecular networks are given. Second,
sometimes the minimum number of steering nodes for complete controllability of a network is too large
in practical applications. Actually in practice, the complete controllability of all nodes is not necessary.
Therefore, an algorithm is developed to identify steering node sets for output controllability, which measures
the controllability of a portion of nodes. The algorithm provides a novel method for drug target identification
in biomolecular networks: the states of disease related biomolecules can be controlled by actuating the
identified steering nodes, which are potential drug targets. Third, to improve feasibility of identified steering
nodes in real applications to biomolecular networks, the ability of steering nodes to bind drugs should
be considered. An algorithm is proposed to identify steering node sets with drug binding preference. It is
expected that steering node sets identified with drug binding preference have more chances to bind to existing
drugs, compared to other feasible steering node sets, which facilitates the subsequent procedures of realizing
the control of biomolecular networks via drugs.
In addition, in this thesis a software system called CytoCtrlAnalyser is implemented, which contains nine
recent algorithms for users to conveniently investigate controllability of biomolecular networks within the Cy-
ii
toscape environment. The algorithms integrated in CytoCtrlAnalyser can be divided into two aspects based
on their functions: identifying steering nodes for different control objectives and qualifying or quantifying
importance of individual nodes to the controllability of networks.
Keywords: Network controllability, biomolecular networks, steering nodes, realistic control
scenarios
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1 Introduction
1.1 Background
There are various biomolecules in a human body, which include estimated 19,000-20,000 human protein-
coding genes [1], ∼1,000 metabolites and an undetermined number of proteins and RNA molecules [2].
Biomolecules perform their functions by interacting with each other and form biomolecular networks, in
which nodes represent biomolecules and edges represent the interactions between them. With the exceptional
development in high throughput technology, large-scale biological data are available, which provides the
foundation for inferring relationships between biomolecules and benefits the reconstructions of different types
of large-scale biomolecular networks, such as gene regulatory networks [3], signal transduction networks [4]
and protein-protein interaction (PPI) networks [5]. Since diverse cellular functions are typically carried
out by the complicated interactions among biomolecules, methods which investigate biomolecular networks
systematically are critical for understanding the mechanisms of various biomolecular systems.
Network science, which focuses on analyzing complex relationships between objects mainly based on the
topology of networks, has provided powerful methods for understanding underlying relationships among dif-
ferent biomolecules and has prompted valuable progress in drug target identification [6, 7], human disease gene
prediction [8], protein complex identification [9], etc. However, studies focusing on topology of biomolecular
networks mainly investigate static relationships between biomolecules whereas biomolecular networks rep-
resent dynamic systems, in which individual nodes are dynamic and affect each other through interactions.
For example, nodes in a gene regulatory network represent genes and each node has a corresponding state
variable which represents the expression level of the gene. Then the edges between genes indicate whether the
expression of one gene would affect the expression of another gene. For a gene regulatory network, different
expression levels of genes indicate different states of the network, which can not be described by network
topological structure. Mathematical models have been developed to describe the dynamics of biomolecular
systems based on biological observations [10]. A variety of celluar processes have been described successfully
[11–13] and lots of promising applications have been made, such as identification of potential drug targets
[14–16]. Nevertheless, modeling and analysing the dynamics of large scale biomolecular networks is still chal-
lenging due to the difficulties of estimating model parameters and the lack of mathematic tools to analyse
the large scale networks.
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It has been discovered that many large scale networks of real systems share some non-trivial topological
features, such as a heavy tail in the degree distribution, high clustering coefficient, community structure,
and hierarchical structure. The networks with these non-trivial topological features are referred to as com-
plex networks and two famous and most studied types of complex networks are scale-free networks [17] and
small-world networks [18]. To understand the dynamics of complex networks, a recent pioneering work has
investigated the controllability of complex networks [19]. The study [19] used the linear structural dynamic
model [20] to describe the dynamics of complex networks. To construct linear structural dynamic models, it
is not necessary to estimate the parameters in the models and the models can be determined based on the
interaction relationship among nodes. In addition, the mathematic descriptions of the controllability of struc-
tural linear models can be formulated as graph-theoretic descriptions, such that the controllability of large
networks can be studied by using graph-theoretic algorithms while it is usually formidable for mathematic
methods. Taking advantage of linear structural models, the study [19] used the maximum matching algorithm
[21] to determine the minimum number of independent input control signals required for having a complex
network completely controllable and a minimum driver node set (MDS), in which each node corresponds to
an input control signal.
Since many biomolecular networks display many features of complex networks, this thesis investigates
the controllability of biomolecular networks based on the linear structural model by extending previous
preeminent works or theorems [19, 20, 22–24]. When perturbing some biomolecules in a biomolecular network,
the states of other biomolecules may also be affected due to the interactions, which may change the state of
the whole biomolecular network. Thus this thesis focuses on identifying the minimum set of steering nodes in
biomolecular networks, such that by proper input control signals, the biomolecular networks are controllable
and the states of biomolecular networks can be steered to desired ones.
1.2 Motivation and objectives
Our final goal of understanding biomolecular networks is to change their states to what we desire. By
changing the states of biomolecular networks, we would be able to modify cellular behaviors or phenotypes.
In order to control a network, the main problem is to identify the steering nodes which should be actuated
by input control signals. Controllability is a concept in modern control theory, which measures the ability
of changing the states of networks by actuating the steering nodes via input control signals. If a network
is completely controllable, it can be steered from any initial state to any final state in finite time with
appropriate input control signals. Recent progresses have been made to understand the controllability of
general complex networks [19, 25, 26]. This thesis focuses on developing methods to identify the minimum
set of steering nodes in biomolecular networks such that the biomolecular networks are controllable according
to network controllability theorems. To control biomolecular networks, many realistic facts of biomolecular
networks should be taken into consideration when identifying the minimum set of steering nodes, such that
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the “controllability in principle” can be realized as the “controllability in practice” [27].
Firstly, previous studies mainly focus on complete controllability of the networks and most of the attention
have been paid to the minimum driver node set (MDS) proposed by Liu et. al. [19]. However, applying
independent input control signals to nodes in an MDS respectively is a necessary but not sufficient condition
for complete controllability of a network. Therefore, methods are required to identify the minimum steering
node sets (MSSs) of biomolecular networks, such that applying independent input control signals to the nodes
in an MSS respectively is a sufficient and necessary condition for complete controllability of a network.
Secondly, two practical constraints are considered in the thesis. On the one hand, when controlling
biomolecular networks, it is difficult and unnecessary to completely control the whole biomolecular network
in many applications. Therefore, algorithms are needed to identify the steering nodes such that the subsets
of biomolecules in biomolecular networks can be controlled. Since the biomolecules which are intended to be
controlled can be considered as outputs of the biomolecular networks, the problem can be formulated as an
output controllability problem. Compared to the MSSs for complete controllability, fewer steering nodes are
required for output controllability, which is more practical and efficient in controlling biomolecular networks.
On the other hand, since steering node sets for the same control objective are not unique and previous
methods of identifying steering node sets only return one possible solution, it could be more feasible if some
practical information of steering nodes is considered. To actuate steering nodes in biomolecular networks,
input control signals are usually chosen from chemical molecules such as drugs. Therefore, steering node
sets which have more chemical-binding opportunities with drugs are more appropriate than randomly chosen
steering node sets when actually realizing the control of biomolecular networks by using drugs. To identify
steering node sets with drug binding preference, firstly schemes are required for quantifying the drug binding
preferences of biomolecules. Then algorithms to identify steering node sets based on preference values are
needed. The identification of steering nodes with drug binding preference provides new methods for drug
target identification and drug repositioning: steering nodes for the controllability of a disease related network
could be potential drug targets while the disease could be a new indication for drugs that can bind to the
identified drug targets.
Finally, controlling complex networks has attracted lots of investigation in recent years, so a software
system which integrates algorithms of network controllability is in demand. Cytoscape [28] is a software
environment for visualizing and analyzing complex networks and a lot of apps, which are actually plug-ins,
are available in the Cytoscape App Store for a variety of problems. Therefore, developing the software for
network controllability as an app in the Cytoscape environment would be easy to access and use, which
would benefit researchers for investigating controllability of biomolecular networks as well as other complex
networks.
Based on these motivations, the objectives of this study are described as follows (see Fig. 1.1):
1. Reviewing currently developed methods for controllability of complex networks and their applications
to biological networks including biomolecular networks.
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2. Developing algorithms for identifying minimum steering node sets for complete controllability of biomolec-
ular networks.
3. Developing algorithms for identifying steering node sets for output controllability of complex networks
and applying them to drug target identification in biomolecular networks.
4. Developing algorithms for identifying steering node sets with drug binding preference for controlling
biomolecular networks
5. Developing a software system that integrates various network controllability algorithms.
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Figure 1.1: Motivation and objectives of the thesis. Objective 1 and Objective 5 aim at summarizing
the studies of network controllability and realizing developed algorithms. Objective 2, Objective 3
and Objective 4 target identifying steering nodes for controlling biomolecular networks. The more
information is considered, the more reliable and practical the results are.
1.3 Organization of the thesis
This is a manuscript-style thesis. The main content of the thesis consists of the works to achieve the objectives,
which is presented in the form of published or prepared manuscripts. At the beginning of each chapter, a
brief introduction is included to describe the connection of the manuscript to the context of the thesis. In
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Chapter 7, a general discussion of correlations of each manuscript is provided. All manuscripts have been
re-formatted for consistency.
The remainder of the thesis is organized as follows: Chapter 2 presents a comprehensive review of control-
lability of complex networks and its applications to biological networks. Chapter 3 introduces a method to
identify MSSs for the complete controllability of complex networks and applications to several biomolecular
networks for validation of the method. Chapter 4 proposes a method to identify steering nodes for output
controllability, which aims to control a subset of nodes in a network instead of completely controlling the
whole network. A typical application of the method is drug target identification: steering nodes are poten-
tial drug targets for controlling disease related biomolecules. Chapter 5 further improves the feasibility of
identified steering nodes for controlling biomolecular networks by selecting steering nodes with drug binding
preference such that the steering nodes have more chemical-binding opportunities with drugs. Chapter 6
presents a software system which integrates nine network controllability algorithms recently developed. Fi-
nally, Chapter 7 summarizes the work in this thesis and discusses some future work of this research. The
copyright permissions of the manuscripts included are in Appendix A.
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2 Controllability of complex networks and its appli-
cations to biological networks
Prepared as: L. Wu, M. Li, J. Wang, and F.-X Wu, “Controllability of complex networks and its appli-
cations to biological networks,” Journal of Computer Science and Technology, submitted, 2018.
This chapter presents a comprehensive review of studies on the controllability of complex networks and
its applications to biological networks. It first introduces different dynamic models of biological networks
and compares the methods for investing controllability of each model. Then, based on linear dynamic model,
methods for identifying steering node sets for various control objectives are surveyed. For applications to
biological networks, biological functions or importance of steering node sets as well as individual nodes playing
different roles in the controllability of biological networks are reviewed. Objective 1 of the thesis is fulfilled
by this chapter.
Abstract
Complex networks have been used to represent many systems of interests in practice. Instead of performing
functions alone, biological elements, such as biomolecules in biomolecular networks, neurons in neuronal
networks or ROIs (region of interest) in brain networks, usually exert their functions through interactions
with others to form various types of biological networks. Since biological networks are dynamic and complex,
their behaviours are hard to be predicted from individual biological elements. Therefore, computational tools
are needed to reveal essential biological mechanisms from a systematic perspective. Controllability, which
is a concept in control theory, has been applied to investigate the dynamics of complex networks recently.
Advances in the controllability of complex networks inspire investigations on the controllability of biological
networks. Studies on controllability of biological networks show promising applications such as identifying
potential drug targets or biologically important biomolecules. However, there is no comprehensive study for
reviewing controllability of biological networks.
In this article, recent advances on the controllability of complex networks and applications to biological
networks are reviewed. First, we briefly compare three dynamic models of biological networks and controlla-
bility of each model. Then we focus on complete controllability and controllable subspaces of networks based
on the structural linear dynamic model, which explores the underlying correlations between the network
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topology and dynamic properties. For complete controllability and controllable subspaces, algorithms for
identifying steering node sets for each control objective are introduced, respectively, where steering nodes are
the nodes which should be directly actuated by input control signals to achieve control objectives. Finally, we
review applications of network controllability theorems to biological networks, in which biological functions
and network topology have been connected from the aspect of control theory.
2.1 Introduction
Biological systems are composed of biological elements that can interact with each other. The structure of
biological systems can be described by biological networks in which nodes are biological elements and edges
connect biological elements that have interactions. Biological processes, which are vital for living organisms
to live, are usually carried out by complicated interactions among a variety of biological elements. Therefore,
studying biological elements and their interactions are critical for understanding the roles of biomolecules
within cells and uncovering the mechanisms of biological processes. With the development of biomedical
techniques, such as high throughput technologies and MRI (magnetic resonance imaging), various types of
biological data have been acquired in a large amount, which benefits the reconstructions of different types of
biological networks [3, 5, 29–32].
Network science is an interdisciplinary academic field that analyzes complex relationships between objects.
Current advances in network science have shown that most real systems share numerous non-trivial topological
features [17, 18, 33], which are the results of the common dynamical principles that govern their emergence
and growth. By studying topological features, network science has provided powerful tools for investigation
of biological networks to excavate underlying relationships among biological elements and to reveal the
essential biological mechanisms from a system perspective. Substantial progresses have been made based on
investigations of biological networks, such as drug target identification [6, 7], human disease gene prediction
[8] and protein complex identification [9].
The ultimate goal of investigating a network is to control its behaviour or state. For biological networks,
the ability of controlling their behaviours manifests the capability of changing phenotypes of biological systems
as desired, which is vital for improving human lives. However, network science mainly focuses on static
topological features while it does not capture dynamics of individual nodes in complex networks. Control
theory, on the other hand, is a relatively well established subject in engineering which deals with the control
of dynamic systems. In 1960s, Kalman pioneered the state-space approach to systems and introduced the
notions of controllability and observability [34], which have become the bases of modern control theory. In
the state-space representation, individual nodes have their own state variables which have specific physical
meanings (e.g. gene expression levels in gene regulatory networks). Because of the interactions among nodes
in a network, actuating the states of some nodes can affect other nodes, which may change the state of
the network. Understanding controllability, which measures the ability to steer a system from any initial
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state to any final state, is critical in implementation of controlling networks. Therefore, several fundamental
questions are raised naturally: How to model the dynamics of complex networks? To what extent are the
interactions among nodes or the topological features related to the dynamics and controllability of complex
networks? How to select a set of steering nodes such that by perturbing the states of these nodes a network
can be steered to a desired state? How to design optimal control strategies under realistic constraints?
What information can we get from biological networks based on network controllability? To answer these
questions, we review recent studies on the controllability of complex networks. In addition, applications of
network controllability to biological networks are discussed specifically, though the developed network control
methods can be applied to other complex networks.
Fig. 2.1 shows the topics and contents of following sections, which are based on the flow for analyzing
controllability of biological networks. To explore the controllability biological networks, the first step is to
determine the dynamic model to represent the dynamics of biological networks. In Section 2, we compare
different dynamic models of biological networks. After the model comparison, we focus on the controllability
of biological networks based on linear dynamic model. Section 3 and Section 4 introduce the network
controllability theorems and proposed methods to identify steering node sets for different control objectives,
respectively. In section 5, recent studies on the controllability of biological networks are reviewed.
Identifying Steering Node Sets
Nonlinear ODE Model Linear ModelBoolean Model Linear Structural System
Transittability 
Complete  
Controllability
Controllable 
Subspace
Output 
Controllability 
Minimal Steering 
Nodes
Constrained 
Control
Preferences Untouchable Nodes
Unilateral 
Control Signals
Control Energy
Steering Node 
Sets
Individual Nodes 
in Controllability Control Energy 
Importance in 
Controllability
Unconstrained 
Control
Control Objectives
Biological Meanings
Network Dynamic Models
Control Paths
Biological 
Networks 
Figure 2.1: Contents in the article and flow of analyzing controllability of biological networks. For the
dynamic models, we first introduce three dynamic models for representation of biological networks.
Current progresses about controllability of networks with different dynamic models are discussed,
respectively. In addition, we illustrate the reasons of focusing on linear dynamic model in this article.
Then we introduce control theorems related to the complete controllability and controllable subspace
of complex networks. Based on the control theorems, methods for identifying steering node sets for
different control objectives are discussed. Finally, we review studies of biological networks from the
perspective of network controllability. Biological meanings of specific steering node sets and individual
nodes that play different roles in network controllability are discussed.
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2.2 Dynamic models of biological networks
To understand the controllability of biological networks, it is important to make clear the dynamic models.
Different dynamic models lead to different analysis methods for controlling complex networks. In this section,
we present several commonly used dynamic models for biological networks and discuss the control of networks
based on these models. By comparing different models, we focus on the controllability of complex networks
based on linear dynamic model.
2.2.1 Boolean dynamic model
For many artificial and natural systems, state variables of individual components have two distinct config-
urations. In 1969, Kauffman introduced the Boolean dynamic model for gene regulatory networks [35]. In
a gene regulatory network, each gene is represented by a node and the values of its state variable is either
0 or 1, which corresponds to expressed or unexpressed. Currently, Boolean dynamic model has become a
powerful tool for describing and analyzing a variety of biological networks, which benefit our understanding
of many biological processes [36, 37].
The Boolean dynamic model of a network with n nodes is represented by the equation:
x(t+ 1) = f(x(t)), (2.1)
where x(t) = (x1(t), ..., xn(t))
T ∈ Bn is a state vector that describes the states of all nodes in the network.
B = {0, 1} is defined as a set that contains two Boolean values. f is a Boolean function that maps Bn → Bn.
To study the controllability of Boolean networks, Cheng et al. developed a method to map a Boolean
dynamic model into a standard discrete-time linear dynamic model, which provides an algebraic framework
for investigating Boolean networks [38]. However, the idea underlying this approach is mapping 2n possible
states of a network into a 2n × 2n matrix [39]. Therefore, it is computationally intractable to test the
controllability of large-scale Boolean networks. In fact, it can be proved that finding an optimum strategy to
control a Boolean network to a desired final state is an NP-hard problem [40]. Though it is computational
intractable for general Boolean networks, Akutsu et al. studied some special cases of networks which have
tree structure or contain no more than one directed cycle [41]. Kim et al. utilized the genetic algorithm to
identify a minimum set of nodes such that by pinning the state of each node in the set to the corresponding
desired final state, the whole network will eventually converge to the desired state [42]. However, genetic
algorithm is a heuristic algorithm which does not guarantee the minimality of identified set.
2.2.2 Nonlinear ODE model
Since biological processes are nonlinear, modeling the dynamics of biological networks by nonlinear ordinary
differential equations (ODEs) is a straightforward idea. Michaelis-Menten kinetics is one of the best-known
models for describing the rate of enzymatic reactions in biochemistry. Because many regulatory processes
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between biological elements are carried out by biochemical reactions, the Michaelis-Menten kinetics is suitable
for modelling different types of biological networks, such as signaling networks [43], metabolic networks [12]
and gene regulatory networks [44].
The general form of dynamics of a network with n nodes is represented by the following equation:
x˙(t) = f(x(t),u(t)), (2.2)
where x(t) = (x1(t), ..., xn(t))
T ∈ Rn is an n-dimensional vector that describes the states of all the n nodes
in the network and u(t) is an m-dimensional vector that corresponds to m independent input control signals.
f is a nonlinear function.
Though great efforts have been devoted to understanding the controllability of nonlinear systems [45–47],
we still lack of general methods to test the controllability of nonlinear systems. In fact, because nonlinear
differential equations rarely have closed form solutions, it is not feasible to develop general theory on nonlinear
controllability. Therefore, a weaker form of controllability called local accessibility of nonlinear dynamics
systems has been investigated [48], where local accessibility measures the ability to reach an open set of
states in the state space from a given initial state.
To steer a nonlinear dynamic network to a desired state, Cornelius [41] proposed a strategy to perturb
the states of nodes such that the network can be steered into the “basin of attraction” of the desired final
state [49]. Once arriving in the basin, the network will evolve spontaneously to the desired final state.
2.2.3 Linear model
Although dynamics of biological systems are nonlinear, linear models have also been applied to describe
the dynamics of biological networks such as gene regulatory networks [50]. To study the controllability
of biological networks, it is reasonable to represent the dynamics of biological networks by linear dynamic
models. First, there are a large amount of tools available from control theory to study systems with linear
dynamics. For example, a sufficient and necessary condition for the controllability of general linear systems
has been developed by Kalman [34]. Second, the controllability of nonlinear systems is structurally similar
to that of linear systems in many aspects. If a network is structurally controllable, then it is controllable for
almost all possible parameter realizations [20]. Therefore, the structural controllability of linear system can
provide a sufficient condition for the controllability of most nonlinear systems [19, 51]. Actually, to develop
strategies for controlling nonlinear networks, the first step is to investigate the controllability of the locally
linearized system [40]. Last but not the least, there is an intuitive connection between the network topology
and the state transition matrix of linear dynamic model, which makes it possible to create dynamic model
for large-scale biological networks based on their topology. Owing to the strong correlations between linear
model and the network topology, studying on linear dynamic model can provide a vision of a previously
proposed question, which is how much is the controllability of biological networks related to their topological
features.
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According to reasons discussed above, in the following sections of this article, we will focus on the con-
trollability of linear systems and biological networks represented by linear dynamic models. For a linear
time-invariant network with n nodes, the dynamics can be described by the equation:
x˙(t) = Ax(t) +Bu(t), (2.3)
where x(t) = (x1(t), ..., xn(t))
T ∈ Rn is an n-dimensional vector that describes the states of all n nodes in
the network. A is an n × n state transition matrix, whose structure is determined by the adjacent matrix
of the network, indicating the regulatory relationships between nodes in the network. Entry aij in matrix A
indicates the intensity of influence from node j to node i. u(t) is an m-dimensional vector of m independent
input control signals. The n ×m matrix B is an input matrix indicating nodes which are directly actuated
by input control signals. A network system described by the equation (2.3) is denoted as system (A,B).
2.2.4 Structural system and graph representation of linear systems
When modeling the dynamics of complex networks, the nonzero entries in matrix A indicate the strengths
of relationships between nodes in the networks. However, in many scenarios, it is not feasible to obtain the
values of nonzero entries in matrix A precisely. For example, although it is feasible to qualify whether there
is a regulatory relationship between two nodes in biological networks, it is difficult to quantify the intensity
of the regulation. In addition, though Kalman’s controllability rank condition has been proposed to test the
controllability of linear systems [34], calculating the rank of controllability matrix of a large-scale network
is computationally intractable. Therefore, it is difficult to test the controllability of a network directly by
Kalman’s controllability theorem. To address these issues, recent studies on the controllability of complex
networks are mainly based on the framework of structural system, which was proposed by Lin in 1974 [20].
In Lin’s study, controllability of structural systems was studied and the sufficient and necessary condition
for structural controllability of structural systems was given. Lin’s result has been proved in different ways
[52–55] and generalized to controllable subspaces [22–24].
When entries in matrices A and B are either fixed zero or independent free parameters, matrices A and B
are called structural matrices and the corresponding system (A,B) is called a structural system. A structural
system (A,B) is called completely structurally controllable if the Kalman’s controllability condition can be
satisfied by freely choosing the values of the independent free parameters in matrices A and B [20]. Besides
completely structural controllability, structural output controllability [24] and structural transittability [56]
have been studied, respectively.
The rationale of investigating the controllability of networks based on the structural system comes from
two aspects. First, the structural linear dynamic model of a network can be created only based on its topol-
ogy and each nonzero entry in A corresponds to an edge in the network. Therefore, for modeling biological
networks, there is no need to consider the types of biological networks, the kinetic models regulating the
dynamics as well as plenty of unknown parameters. Second, if a structural system (A,B) is structurally
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controllable, most of its parameter realizations which are denoted as admissible systems (A˜, B˜) are control-
lable, where (A˜, B˜) can be obtained by assigning some specific values to the free parameters of (A,B) [20].
Therefore, if a network is structurally controllable, no matter how to choose the values of unknown regula-
tory strengths, the probability that the network is controllable is almost 100%, except some cases that the
unknown regulatory strengths satisfy some constraints (equations). Therefore, the structural controllability
analyses can provide reliable results for real networks even though their parameters are unknown.
Each structural system (A,B) can be represented by a digraph G(A,B) = {V,E}, where V = VA
⋃
VU
is a node set and E is an edge set. Nodes in VA = {v1, ..., vn} correspond to nodes in network under
investigation and nodes in VU = {u1, ..., um} correspond to the input control signals represented by u(t).
E = {vj → vi, uk → vl|aij 6= 0, blk 6= 0} consists of edges among nodes and edges from control signals to
nodes. The subgraph of G(A,B) induced by the node set VA is denoted as G(A), which is the original network
without input control signals. Fig. 2.2 is an example of the system (A,B) and its graph representation.
a
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0 0 0 0 0 0
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⎥
⎥
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Figure 2.2: Graph representation of a network system. (a): G(A,B) corresponds to system (A,B).
(b): The state transition matrix A and input matrix B of the system (A,B).
With graph representation of structural systems, algebraic structural controllability conditions can be
converted to graph-theoretic forms. Therefore, various graph-theoretic algorithms can be applied to inves-
tigate structural controllability of complex networks, which is more computationally feasible for large-scale
networks compared to algebraic methods. Taking the advantages of structural controllability, Liu et al. [19]
recently applied the concept of structural controllability to complex networks. Liu’s research inspired several
research progresses on network controllability, such as the controllability of networks with edge dynamics
[57] or nodal dynamics controllability [58], robustness of network controllability [59] and enhancing network
controllability (reducing input control signals) via minimal structural perturbations [60]. In addition, a
comprehensive platform has been developed for analyzing the controllability of complex networks [61].
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2.3 Network controllability theorems
Since linear systems has been deeply studied in control theory, a variety of controllability theorems have been
proposed, which paves the way to understand the controllability of complex networks. In addition, taking the
advantages of structural controllability, connections between the network topology and controllability can be
established. In this section, we introduce some important theorems of network controllability.
2.3.1 Complete controllability of complex networks
A network is completely controllable if it can be steered from any initial state x(0) to any desired final state
x(tf ) in finite time tf with appropriate control signals. Condition for complete controllability is given by the
following theorem:
Theorem 2.1 (Kalman’s controllability theorem [34]). System (A,B) is completely controllable if and only
if the n× nm controllability matrix
C =
[
B AB A2B ... An−1B
]
(2.4)
has full row rank of n.
To interpret this criterion, the equation 2.3 can be solved in the following form:
x(t) = eAtx(0) +
∫ t
0
eA(t−τ)Bu(τ)dτ. (2.5)
On the right-hand side of equation 2.5, the first term corresponds to the state that the network will be without
any control signals and the second term represents the effect of control signals on the network. eA(t−τ)B
can be expanded in series, which is a linear combination of the columns in controllability matrix C. When a
network is completely controllable, the final state x(tf ) could be any state in the n-dimensional state space.
On the one hand, if rank(C) < n, columns in C will not contain a full basis to span the entire n-dimensional
state space (See Fig. 2.3). Then there exist some final states xtf , such that by letting x(tf ) = xtf , equation
2.5 has no solution for u. On the other hand, if rank(C) = n, columns in C contain a full basis. Given any
desired final state xtf and let x(tf ) = xtf , an appropriate input vector u can always be solved based on
equation 2.5. Therefore, the system is completely controllable.
For a structural system (A,B), the rank of C is a function of independent free parameters in A and
B. The maximum value of the rank of C is defined as the generic dimension of the controllable subspace of
structural system (A,B) and denoted by GDCS(A,B). A structural system (A,B) is completely structurally
controllable if and only if GDCS(A,B) = n, which means it is possible to choose the values of the free entries
in matrices A and B such that the Kalman’s controllability rank condition is satisfied.
A graph-theoretic condition for structural controllability (Theorem 2.2) has been developed in previous
studies [20, 22, 23]. Before presenting Theorem 2.2, we introduce following two definitions (See Fig. 2.4 for
example):
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Figure 2.3: Uncontrollable network system (A,B). (a): G(A,B) corresponds to system (A,B). (b):
The controllability matrix of system (A,B). (c): Controllable subspace. Suppose x(0) = 0, state of
the network will be kept in a subspace, which is the plane a31x2(t) = a21x3(t), no matter how to
choose the input control signal u1(t).
Definition 2.1 (Accessibility [20, 62]). In digraph G(A,B), a node vi in VA is called accessible if and only
if there exists a directed path from the input vertices VU to vi , otherwise vi is inaccessible.
Definition 2.2 (Dilation [20, 62]). The digraph G(A,B) contains a dilation if and only if there is a subset S
of VA such that |T (S)| < |S|, where T (S) = {vj |(vj → vi) ∈ E and vi ∈ S} and E is the edge set of G(A,B).
The input nodes are not allowed to belong to S but belong to T(S). |S| or |T (S)| is the cardinality of set S
or T(S), respectively.
v3
u1
v1
v3v2v2
v1
u1D b
Figure 2.4: Inaccessible nodes and dilation. (a): There is no path from u1 to v3. Therefore, nodes
v3 is inaccessible. Nodes v1 and v2 are accessible. (b): Consider a set S = {v2, v3}, we have the
T (S) = {v1}. Because |T (S)| < |S|, there exists a dilation. According to Theorem 2.2, systems in (a)
and (b) are both structurally uncontrollable.
Theorem 2.2 (Completely structural controllability theorem [20, 62]). A structural system (A,B) is com-
pletely structurally controllable if and only if:
i) there is no dilation in the digraph G(A,B).
ii) all nodes in VA are accessible.
There is an equivalent expression of condition i): all the nodes in VA can be covered by node disjoint
simple cycles or simple paths starting from nodes in VU . In a graph, a simple path is a sequence of edges
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{(v1 → v2), (v2 → v3), ..., (vk−1 → vk)} where all the nodes {v1, v2, ..., vk} are distinct. If v1 = vk and other
nodes are distinct, the sequence of edges is called A simple cycle.
2.3.2 Control in subspaces
In many practical problems, it is neither feasible nor necessary to completely control a network, which prompts
researchers to develop methods for controlling parts of a network. Though a system may not be completely
controllable sometimes, it remains controllable within a subspace (See example in Fig. 2.3c). Having a system
controllable within a subspace is enough for many real applications. In addition, it is natural that ensuring
the controllability within a restricted subspace will require fewer steering nodes being actuated by input
control signals than ensuring controllability within the whole state space. Therefore, several approaches have
been proposed to investigate the controllability of networks within subspaces.
Controllable subnetwork
For structural system (A,B), the dimension of its controllable subspace is measured by GDCS(A,B), which
is the maximum rank of the controllability matrix C by arbitrarily choosing the values of independent free
parameters. Hosoe has proved [22] that if all nodes in a network system (A,B) are accessible, then
GDCS(A,B) = max
G∈G∗
{|E(G)|}, (2.6)
where G∗ denotes the set of subnetworks of G(A,B) which can be spanned by a collection of vertex-disjoint
cycles and at most m simple paths (correspond to m control signals). |E(G)| is the number of edges in
G. Actually, each subnetwork in G∗ is completely controllable. Therefore, the dimension of its controllable
subspace GDCS(A,B) equals to the number of edges in the largest controllable subnetwork in set G∗.
Consider the structural system (A,B) in Fig. 2.3, the corresponding G∗ consists of two subnetworks of
G(A,B) induced by node sets {u1, v1, v2} and {u1, v1, v3}, respectively. According to Hosoe’s controllable
subspace theorem, the GDCS(A,B) of system in Fig. 2.3 is 2, which suggests the whole network can be
steered in a 2-dimensional state space. Suppose the network is at the origin at time t = 0, it can be observed
that the states of nodes v2 and v3 must satisfy the equation a31x2(t) = a21x3(t). But if we only need to
control the subnetwork induced by nodes {v1, v2} or {v1, v3}, it is enough by actuating node v1 alone.
Based on Hosoe’s controllable subspace theorem, recent studies investigated the controllable subspaces or
completely controllable subnetworks from different perspectives, which supplement the theoretical foundation
of structural controllability of complex networks. Liu et al. [63] defined the control centrality to measure the
ability of individual nodes to control a network. Control centrality of node i is defined as GDCS(A, b(i)),
where b(i) is a vector with a single nonzero ith entry. The higher control centrality of node means by
actuating only the node with input control signal, the whole network can be steered in a larger dimension
of its state space or a larger subnetwork can be completely controlled. Control centrality can be extended
to cases in which more than one node are actuated by control signals. Based on this observation, Iudice et
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al. [64] introduced the network permeability, which measures the propensity of a network to be controllable.
To calculate the permeability, Indices solved a problem related to control centrality at first: identifying m
steering nodes from a network with n nodes, such that the corresponding GDCS(A,Bm) is maximized, where
Bm is an n×m controllability matrix corresponding to m steering nodes. Then the permeability is defined
as:
µ =
∫ n
0
(GDCS(A,Bm)−m)dm∫ n
0
(n−m)dm
=
2
n2
∫ n
0
(GDCS(A,Bm)−m)dm.
(2.7)
According to the definition, for a network with a high permeability, a large controllable subspace can be
obtained or a large subnetwork can be completely controlled by actuating a relatively small set of steering
nodes. In order to find a subnetwork which is easy to be controlled with less steering nodes, Liu and Pan [65]
proposed a method to choose subnetworks that are important and easy to be controlled in network systems.
Then the authors applied this method to multiple real networks and discovered that nodes in the subnetworks
chosen by this method tend to be essential. In another study, Commault et al. [66] claimed that though
the dimension of the controllable subspace is constant for almost any parameter realization of a structural
system (A,B), the subspace itself is a function of these parameters. Therefore, the authors defined a concept
called fixed controllable subspace, which is the intersection of the controllable subspaces of all parameter
realizations whose dimension of controllable subspace equals to GDCS(A,B).
Output (Target) controllability
In real applications, we are interested in controlling a specific subset of nodes or a subnetwork of interest.
Since the subset of nodes can be considered as the output of the network, Wu et al. [67] formulated the
problem of controlling a predefined subset of nodes in a network as a network output controllability problem.
Gao et al. [68] proposed the same idea in an independent study, in which they referred to as target control.
The outputs of a linear dynamic system (A,B) can be described by the following equation:
y(t) = Cx(t), (2.8)
where y(t) = (y1(t), ..., yp(t))
T
is an output vector in which each entry represents an output. C is a p × n
matrix that indicates the outputs of the network. A system described by equations (2.3) and (2.8) is denoted
by matrix triplet (A,B,C). For target controllability, the outputs are defined as the states of a set of nodes
in the network. Then it is assumed that there is one and only one nonzero entry in each row of C such
that y(t) is a p-dimensional vector that each entry corresponds to the state of one node. Therefore, target
controllability is a special case of output controllability.
A network is output controllable if its outputs can be steered from any initial state y(0) to any desired
final state y(tf ) in finite time tf with appropriate control signals. To test the output controllability of a
system (A,B,C), a p×mn output controllability matrix is defined as:
oC =
[
CB CAB CA2B ... CAn−1B
]
. (2.9)
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The condition of output controllability is given by the following theorem in control theory:
Theorem 2.3 (Output controllability theorem [69]). System (A,B,C) is output controllable if and only if
rank (oC) = p.
For a structural system, the rank of oC can reach a maximum value by arbitrarily choosing the values of
independent free parameters in A, B and C. The maximum value is defined as the generic dimension of the
controllable output subspace of structural system (A,B,C) and denoted by GDCOS(A,B,C). The struc-
tural system (A,B,C) is called structurally output controllable if GDCOS(A,B,C) = p [24, 70]. Though
theorem 2.3 presents conditions for output controllability, there is no method to calculate GDCOS(A,B,C)
of structural system (A,B,C). Murota and Poljak [24] have developed a method to determine the upper and
lower bounds of GDCOS(A,B,C).
Transittability
Output controllability measures the ability of a predefined subset of nodes that can be steered by input
control signals. However, the states of nodes out of the predefined subset are not considered during control
processes. On the other hand, Wu et al. [56] introduced a new concept called transittability of networks,
which measures the ability of transition between two specific states of complex networks. Transittability
takes the states of all nodes into consideration as well as reduces the required steering nodes compared to
complete controllability.
For system (A,B), it is called transittable between these two specific states x0 and x1 if there exists input
control signals u(t), t ∈ [0, tf ], by which the system (A,B) can be transited between two specific states
x(0) = x0 and x(tf ) = x1. A sufficient and necessary condition for transittability controllability is given by
the following theorem:
Theorem 2.4 (Transittability theorem [56]). With either specific state x0 or x1 ∈ span{C}, system (A,B)
is transittability between x0 and x1 if and only if
rank(C) = rank(C¯),
where C¯ =
[
B¯ AB¯ A2B¯ ... An−1B¯
]
and B¯ = [x0 − x1, B].
Similarly to structural controllability, a structural system (A,B) is called structurally transittable between
two specific structural states x0 and x1 if there exists an admissible system (A˜, B˜) (with respect to (A,B))
and admissible states x˜0 and x˜1 (with respect to x0 and x1, respectively) such that the system (A˜, B˜) is
transittable between states x˜0 and x˜1. In fact, for structure systems, the transittability between two structure
states actually measures the ability to control a subset of nodes in the network without disturbing other nodes.
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2.4 Identification of steering node sets
In order to control a network, the first step is to identify a set of steering nodes which should be actuated
by input control signals. A network system is completely controllable if each node is directly actuated by a
distinct input control signal. However, it is costly and impractical for large networks. Therefore, methods
are required to identify minimal steering node sets such that the the control objective can be satisfied. The
identification of steering nodes for controlling networks can be viewed as problems of determining appropriate
control matrix B when a network, which is represented by A, is given. Theorem 2.2, 2.3 and 2.4 provide
conditions to judge if a structural system (A,B)/(A,B,C) is completely structurally controllable, structurally
output controllable or transittable between two specific states. However, for a given network (matrix A),
controllability theorems do not indicate a set of steering nodes (matrix B) such that the network system is
controllable. A brute-force search for a minimal steering node set would require checking the controllability
conditions for almost 2n distinct controllability matrices B, which is computationally prohibited. In this
section, methods for identifying steering node sets for different control objectives are reviewed.
2.4.1 Steering nodes for complete controllability
The minimum driver node set (MDS) [19] and the minimum steering node set (MSS) [62] are two mostly
investigated steering node sets for completely controlling networks. Recently, graph-theoretic methods have
been proposed to identify MDSs and MSSs of networks based on theorem 2.2.
The MDS is a minimum set of nodes in which each node should be actuated by an independent control
signal such that the condition i (“no dilation” condition) of structural controllability theorem 2.2 can be sat-
isfied. However, applying independent control signals to an MDS does not guarantee complete controllability
of the network and it is a necessary condition for completely controlling a network. In [19], identification of
MDS has been formulated as a maximum matching problem in an undirected bipartite graph corresponding
to the original network. A matching on an undirected graph is a set of edges without common nodes and
a maximum matching is a matching with the largest size. To identify an MDS, a bipartite graph which
contains node sets R = {r1, · · · , rn} and C = {c1, · · · , cn} is constructed. The nodes ri and ci correspond to
the node i of G(A). If there is a directed edge from node i to j in G(A), there is an edge in the bipartite graph
connecting rj and ci. A maximum matching in bipartite graph can be solved by Hoproft-Karp algorithm
[71]. Then the MDS are corresponding to the nodes in R that are not connected to any matching edges (See
Fig. 2.5b). It can be verified that if each node in MDS is actuated by an input control signal, which means
adding a control node ui for each node i in the MDS, the resulting graph G(A,B) will have no dilation. Since
MDSs of a network are not unique, Zhang et al. [72] proposed a preferential matching algorithm to identify
MDSs that have a specific degree property.
The MSS is a minimum set of nodes in a network which should be actuated by control signals to completely
structurally control the network. Compared to the MDS, applying independent control signals to an MSS
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guarantees the complete controllability of the network and it is a sufficient and necessary condition for
completely controlling a network, which satisfies both conditions of structural controllability theorem 2.2.
In [62], the bipartite graph in identification of MDS has been extended to a directed graph. The authors
proved that a minimum cost maximum flow (MCMF) in the constructed digraph corresponds to an MSS of
the network (See Fig. 2.5c). The algorithm for solving the MCMF problem can be found in [73]. Similar to
the MDS, MSSs of a network are not unique as well. Therefore, Wu et al. [74] developed an approach to
identify MSSs with preference, such that the average preference value of nodes in the identified MSS is the
maximum among all possible MSSs of the network.
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Figure 2.5: Identification of an MDS and an MSS by maximum matching and minimum cost max-
imum flow method, respectively. (a): A network G(A) and its corresponding system state transition
matrix. (b): The corresponding undirected bipartite graph and the maximum matching. Nodes r4
and r7 in node sets R are not matched in the maximum matching, which suggests v4 and v7 make
up an MDS. (c): A directed graph constructed according to the structure of G(A) and the minimum
cost maximum flow. The labels on edges represent flow, capacity and cost per unit flow, respectively.
There is no flow passing through r4 and r7, which suggests v4 and v7 belong to an MSS. The flow
passes through one edge with cost 1, which means there is an additional steering node which should
be chosen from the corresponding source strong connective component (SCC). Then nodes v4, v7 and
vi(i = 1, 2, 3) make up an MSS.
Several studies investigated the identification of steering nodes under constraints, which are common in
real applications. Pequito et al. [75] proved that the minimum constrained input selection (minCIS) problem,
which selects minimum number of inputs from a given set of possible inputs, is NP-hard. When there are n
possible inputs and each input can actuate a distinct node of the network, the minCIS problem reduces to
the problem of identification of MSS, which could be solved in polynomial time.
Stepping out of structural controllability, some studies considered constraints from the aspects of input
control signals and control energy. Lindmark and Altafini [76] studied the controllability of complex networks
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with unilateral inputs, which assumes that an input control signal is either negative or positive, but not
both. This constraint on control signals makes sense in many scenarios. For instance, input control signals
of biological networks are usually drugs or chemical molecules, which can only either activate or inhibit
their targets nodes. Conditions for unilateral controllability have been formulated algebraically in terms of
eigenspaces of the system matrix A. Compared to unconstrained control, more steering nodes are required to
achieve complete controllability for unilateral control. By studying several instances with randomly weights
assigned to the edges, the authors discovered that the number of additional steering nodes for unilateral
control is strongly related to the number of roots and dilations in a network. Then a lower bound of minimum
number of steering nodes required for unilateral controllability can be determined by network structure alone.
In many cases, though actuating an MSS can completely control a network theoretically, the associated
control cost can be unbearably large, which prevents actual control from being realized physically. The
control cost can be measured by control energy, which is defined as:
E(tf ) =
∫ tf
0
(uTt · ut)dt, (2.10)
where ut are input control signals [77]. Wang et al. [78] proposed physical controllability which considers the
probability of achieving control practically. By investigating control energy for controlling chain structures in
networks, the authors provided strategies to make physically uncontrollable networks physically controllable
by properly adding additional steering nodes. Li et al. [79] studied the problem of identifying a fixed number
of steering nodes, such that a network can be completely controllable with the minimum energy. The authors
formulated the original problem as an optimization problem and developed two methods to solve it.
2.4.2 Steering nodes for output controllability
It has been proved that identifying the minimum number of steering nodes for structural output controlla-
bility is an NP-hard problem [80], where the outputs are defined as the states of a set of nodes. In Wu’s
study [70], the lower bound of GDCOS(A,B,C) [24] has been applied to design an algorithm to identify
steering nodes for output controllability, which guarantees that the network is output controllable by actuat-
ing identified steering nodes. Therefore, actuating the identified steering node set is a sufficient but may not
be a necessary condition for structural output controllability. The identification of steering nodes for output
controllability has been formulated to maximum weight complete matching problem in a bipartite graph
constructed according to network topology and a predefined set of nodes to be controlled. The maximum
weight complete matching problem can be solved by the Kuhn-Munkres (KM) algorithm [81]. Fig. 2.6 is an
illustrative example for identifying steering nodes for controlling a subset of nodes in a network.
In Gao’s study [68], a greedy algorithm has been developed to identify steering nodes which are sufficient
for target control. Several further studies developed algorithms to identify steering nodes for target control-
lability by reducing the number of steering nodes or considering realistic constraints. Instead of using the
greedy algorithm, Zhang et al. [82] developed an algorithm which elaborately rearranges the matching order
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Figure 2.6: Identifying steering nodes for output controllability. (a): A network. The outputs of the
system are the states of grey nodes v1, v2 and v3. (b): A corresponding weighted bipartite graph. The
weights of red lines, green lines and black lines are 1, 0 and −1, respectively. (c): A maximum weight
complete matching in (b). Since r1 matches a node in set U
′ = {u′i|i = 1, . . . , 6}, node v1 makes up a
steering node set for output controllability, which suggests that the states of nodes v1, v2 and v3 can
be controlled by actuating node v1 only.
of the nodes such that the required number of steering nodes for target control can be significantly reduced.
The comparison results on model generated networks and real networks indicate that the proposed algo-
rithm outperforms Gao’s algorithm [68]. Because the functions of network systems intensively depend on the
connections between nodes, Liu et al. [83] investigated target controllability of giant connected components
of directed networks by selecting target nodes from giant connected components, which are the connected
components of networks that have constant fractions of nodes in networks. In the study, the relationships
between the number of steering nodes for controlling giant connected components and the parameters of
model generated networks are explored. Piao et al. [84] considered controlling a subnetwork called target
community of a complex network when the whole topological structure of the network is not available. The
authors argued that though a target community is controllable with steering nodes identified by structural
controllability analysis, determining input control signals that are able to achieve a given control goal can be
very difficult. It is because the process of controlling target communities would be influenced by signals from
the remainder network, but the topology and state of the remainder network is not available. To deal with
this issue, the author defined a type of steering nodes, which they refer to as immune nodes, for blocking
signals transmitting from the remainder network. Then they proposed a method to reduce the total number
of steering nodes and immune nodes such that the subnetwork is completely controllable and the signals from
the reminder network can be blocked.
By considering some practical constraints, Guo et al. [85] proposed the concept called constrained target
controllability of complex networks, which concerns the target controllability by selecting steering nodes from
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a predefined constrained node set. Then the authors developed an algorithm to identify steering nodes from
a constrained node set for controlling a set of target nodes. Iudice et al. [64] also investigated the target
controllability of networks by not only considering the constraints on selection of steering nodes, but also
introduced a set of untouchable nodes, whose states should not be perturbed during the control process.
2.4.3 Steering nodes for transittability
In addition, Wu et al. [56] developed an algorithm to identify steering nodes with a given network G(A) and
a set of nodes whose states are supposed to be changed during state transition. Identification of steering
nodes for transittability has been formulated to maximum weight complete matching problem in a bipartite
graph constructed according to network G(A) and structural states. Fig. 2.7 is an illustrative example of
identifying steering nodes for state transittability. The result indicates that by actuating nodes v1 and v3 with
input control signals, the states of nodes v1, v2 and v3 can be controlled without affecting nodes v4, v5 and
v6, which is different from the example of output controllability in Fig. 2.6: the states of nodes v1, v2 and v3
can be controlled by actuating v1; however, the state of v4 might be perturbed as well. Transittability usually
needs more steering nodes for controlling the states of target nodes compared to output controllability, but
requires less steering nodes than completely controlling the whole network.
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Figure 2.7: Identifying steering nodes for state transittability. (a): A network. Grey nodes v1, v2
and v3 could be changed to any states in finite time while states of white nodes would not be affected
by control signals at the end of the control process. (b): A corresponding weighted bipartite graph.
The weights of red lines, green lines and black lines are 1, λ and 0, respectively, where λ is a small
enough positive number. (c): A maximum weight complete matching in (b). Since r1 and r3 match
green lines, nodes v1 and v3 make up a steering node set for state transittability.
2.5 Applications to biological networks
Studies introduced in previous section offer powerful tools to systematically identify steering node sets in
controlling states of complex networks. The steering nodes are identified based on the control theory, which
guarantees the controllability of networks theoretically. However, theoretical analyses on structural control-
lability of complex networks do not explain how to manipulate the steering nodes to steer networks from one
state to another, which depends on the details of connections and interactions in the networks. Therefore,
there is a gap between “controllable in principle” and “controllable in practice” [27]. Though structural
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controllability approaches are not able to provide explicit strategies to control complex networks in practice,
they still offer a novel perspective to investigate topology of complex networks from the aspect of control
theory. In this section, we review recent studies that explored various types of biological networks, including
biomolecular networks, neuronal networks and brain networks, based on network controllability.
2.5.1 Steering node sets in biological networks
By applying input control signals to steering node sets, networks can be steered to the desired states. There-
fore, recent studies explored the biological meanings of steering node sets in biological networks for different
control objectives, which are complete controllability, output controllability and transittability.
MDSs of biological networks are one of the most investigated steering node sets for completely controlling
networks. Khazanchi et al. [86] compared driver nodes in MDSs and hub nodes of 4 different protein-protein
interaction (PPI) networks. They found that hub nodes are more likely to be lethal proteins while driver
nodes tend to be transcription factors. In addition, they found that driver nodes are enriched in first-degree
neighbors of hubs, which suggests that one should control the nodes interacting with the hubs, instead of
controlling the hubs directly, to control networks. Badhwar and Bagler [87] identified the MDS of C. elegans
neuronal network. By investigating the phenotypic properties and the genetic correlations of driver neurons
in the MDS, they found that driver neurons are primarily motor neurons located in the ventral nerve cord and
contribute to biological reproduction, which demonstrates the importance of driver neurons and their ability
of controlling the behaviours of the organism. Noori et al. [88] constructed a comprehensive neurochemical
network of the rat brain and identified an MDS of the rat brain network. Interestingly, one of the four
steering nodes in the identified MDS, subthalamic nucleus (STh), has already been proved to be crucial in
global circuit dynamics [89] and treatment of Parkinson disease as well as other disorders [90] by numerous
deep brain stimulation studies. This observation manifests an agreement between structural controllability
and function of neuronal networks.
For the MSSs of biological networks, Wu et al. [62] applied their method of identifying MSS to the
S.cerevisiae cell cycle networks [11, 13], Epithelial to Mesenchymal Transition (EMT) network [91] and
myeloid differentiation regulatory network [37]. It has been discovered that steering nodes in MSSs of these
networks play critical roles in triggering cell division process, maintaining homeostasis of epithelial or regulat-
ing early myeloid development as well as hematopoietic stem cells, respectively. Since the identified MSSs in
these networks are closely related to dynamic behaviours of the networks, it is fair to suggest their importance
in controlling the networks. In a further study on MSSs, Wu et al. [92] improved the algorithm of identifying
MSSs by considering the preference of individual nodes, such that nodes in the identified MSS have higher
preference values compared to nodes in other eligible MSSs of a network. The algorithm has been applied
to study MSSs with drug binding preference of some biological networks. The biomolecules in the MSSs
with binding preference are enriched with known drug targets and are likely to have more chemical-binding
opportunities with existing drugs compared with randomly chosen MSSs, suggesting novel applications for
23
drug target identification and drug repositioning.
There is an intuitive application of output controllability to biological networks, which is drug target
identification. Wu et al. [70] formulated the problem of drug target identification as a problem of identifying
steering node set for output controllability of biological networks. In the study, disease biomolecules and
biomolecules whose state changes would lead to side effects are defined as the outputs of the network,
which takes both efficiency and safety into consideration. The steering nodes for controlling these two types
of biomolecules are considered as potential drug targets. The method has been applied to several real
biological networks. The identified potential drug targets are targets of approved drugs or in agreement
with existing research results, which indicates the feasibility of the method. By considering the constrained
target controllability, Guo et al. [85] applied the developed algorithm for identifying steering nodes to a
gene regulatory network related to type 1 diabetes. By defining the five genes related to type 1 diabetes as
the target nodes and all FDA-approved drug targets as the constrained node sets, they found that FASLG
and CD80 are steering nodes for controlling the target nodes related to type 1 diabetes, which is supported
by previous wet experiments. In another study, Kanhaiya et al. [93] built three PPI networks for breast,
pancreatic and ovarian cancer, respectively. The authors considered survivability-essential proteins specific
to each cancer type as control targets in each network. A method is also proposed to identify steering nodes
among FDA-approved drug target nodes. Different from the method in Guo’s study [85], selection of steering
nodes from FDA-approved drug targets is not obligatory, but is preferred in Kanhaiya’s study. The results
indicate that many steering nodes are known drug targets for cancer therapies, but some of them are not the
drug targets corresponding to cancer types. Besides identifying steering nodes for drug target identification,
Yan et al. [94] predicted the involvement of each C. elegans neuron in locomotor behaviours by formalizing
the responsive mechanism of C. elegans to external stimuli as a target control problem. The predictions based
on the target control of network have been validated by their experiments. For example, it has been predicted
that three neurons (DD04, DD05, or DD06) in the DD motor neuronal class should affect locomotion when
ablated individually. Their experimental validation shows that ablations of DD04 or DD05 have impacts
specifically on posterior body movements, whereas ablations of other neurons in the DD motor neuronal class
(DD02 or DD03) do not affect the locomotion. Yan’s study not only provides a novel method to unveil how
the structure of neuron network affects its functions based on controllability perspective, but also offers the
first experimental proof of the validity of network structural controllability analyses.
For transittability, Wu et al. [56] employed different biological systems with different phenotypes to
validate the applicability of identified steering node sets for transittability. For example, T helper cells (Th
cells), which play an important role in the immune system, are a sub-group of lymphocytes. A network
has been constructed by Mendoza [95] to model the differentiation of Th cells. Matured Th cells can be
classified as Th0 (precursor), Th1 and Th2 (effector) cells, which correspond to three different states of Th
differentiation network. Steering node sets for state transitions among these three phenotypes have been
identified by the proposed algorithm. According to the transittability analyses, actuating steering nodes
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SOCS1 and T-bet can steer the network between Th0 and Th1 and actuating nodes IL-4 and GATA3 can
steer the network between Th0 and Th2, which is in agreement with existing knowledge [96, 97]. Actuating
steering nodes T-bet and GATA3 can cause the transition between Th1 and Th2, which is completely in
agreement with the experimental data [98].
2.5.2 Roles of individual nodes in controllability
Instead of focusing on specific steering node sets for different control objectives, several studies proposed
methods to quantify the importance or analyze the roles of individual nodes in controlling networks and then
investigated biological meanings of nodes based on the proposed methods. The analyses were mainly based
on the importance of nodes in network controllability, control energy and control paths.
Since the MDSs or MSSs of a network are not unique, the algorithms for identifying MSSs or MDSs do
not result in a unique set of MDS or MSS. Therefore, studies attempted to figure out the importance of
nodes in network controllability by classifying nodes into different categories or assigning centrality values
to individual nodes according to the times of a node appears in all possible MDSs of a given network. Jia
et al. [99] classified a node in the network as critical, intermittent or redundant if it acts as a driver node
in all, some or none of all possible MDSs, respectively. By classifying nodes in a human signaling network,
Liu et al. [100] discovered that critical nodes are enriched in the group of ligands, intermittent nodes are
enriched in cell surface receptors and redundant nodes are enriched in intracellular signaling proteins. They
also found that cancer-associated genes are enriched in redundant nodes, which suggests that controlling the
regulators of the cancer-associated genes could be more feasible than controlling the cancer-associated genes
directly. In a related work of the classification, Jia et al. [101] proposed a concept called control capacity,
which is defined as the likelihood that a node is a driver node in an arbitrary MDS. Liu et al. [102] calculated
the control capacity of nodes in a human liver metabolic network and classified nodes into critical, high-
frequency and low-frequency nodes based on their control capacity values. They found that in the metabolic
network, critical metabolites are likely to be essential metabolites while the high-frequency metabolites tend
to participate in different metabolic pathways.
Though the MDSs of a network may not be unique, the cardinality of all the MDSs are the same.
Vinayagam et al. [103] classified a node in a network as indispensable, neutral or dispensable, which correlated
to increasing, no effect, or decreasing the cardinality of the MDSs of the network by removing that node and
edges which connected to the node. Then the authors applied their classification strategy to a directed human
PPI network and found that indispensable proteins or corresponding genes are enriched in essential genes,
human virus targets, drug targets or disease-causing mutations. Their study provides a novel classification
strategy based on network controllability. Nodes in different categories show distinct biological properties
in the context of essentiality, evolutionary conservation, and regulation of translational or post-translational
modifications. In fact, before the work of Vinayagam et al., Matsuoka et al. [104] identified the indispensable
nodes, which they called “critical node” in their study, of an influenza A virus life cycle network. They found
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that the indispensable nodes are important factors of the viral life cycle, which are known drug targets or could
be potential therapeutic targets. In another work, Uhart et al. [105] studied a directed phosphorylation-based
PPI network by analyzing the biological characteristics of indispensable nodes. Because post-translational
modification and inhibition of transduction by miRNAs are two important mechanisms of regulation in
eukaryotic cells, it is meaningful to evaluate the relationship between proteins that are important in controlling
the network and these two mechanisms. It has been discovered that indispensable nodes are more enriched in
post-translational modifications and miRNA targets, which indicates that indispensable nodes are targets of
intense biological regulation. Uhart’s study provides a deeper understanding of the controllability of biological
networks and bridges the controllability theorems and cell regulation processes, such as post-translational
modification, in a phosphorylation-based PPI network.
In a recent work, Ravindran et al. [106] combined two types of classification strategies and investigated
a cancer signaling network. Nodes are classified as critical, intermittent or redundant based on Jia’s clas-
sification strategy and indispensable, neutral or dispensable based on Vinayagam’s classification strategy.
Then authors analyzed the distribution of cancer genes and targets of anti-cancer drugs in each node class.
Enrichment analyses show that redundant nodes, especially indispensable redundant nodes are enriched in
both cancer genes and anti-cancer drug targets, which implies a strong correlation between indispensable re-
dundant nodes and cancer development or cancer treatment. This study indicates that the two classification
strategies can capture the roles that individual nodes play in controlling a network from different aspects.
Therefore, it is likely to get more comprehensive results by combining these two classification strategies.
By investigating topological features of steering nodes in MDSs, Ruth et al. [107] found that each
driver node in MDSs corresponds to one of three topological features: source nodes, external dilations
and internal dilations. Sources nodes are nodes that have no incoming edges and the number of source
nodes is denoted as Nsource. External dilations appear when sink nodes, which are nodes without outgoing
edges, outnumber source nodes. The number of sink nodes is denoted as Nsink and then the number of
external dilations equals to Nexternal = max(0, Nsink −Nsource). Internal dilations are dilations other than
external dilations and the number of internal dilation is denoted as Ninternal. Then the cardinality of MDSs
NMDS = Nsource +Nexternal +Ninternal, which is the sum of the three topological features. Then the driver
nodes can be classified into three categories based on their corresponding topological features. The authors
discovered that the MDSs of a network is usually dominated by a specific topological feature. According
to the proportions of each types of driver nodes, a network can be classified as source dominated, external-
dilation dominated or internal-dilation dominated. The classification of networks has been tested on various
of real networks. The results offer insights into the relationship between topology and functions of complex
networks. For example, neural networks are source dominated, which tend to allow relatively uncorrelated
behaviors and are suitable for distributed processing.
Control energy has also been applied to uncover the roles of individual nodes in the controllability of
networks. Gu et al. [32] studied the controllability of a human brain network, in which each node represents
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a region of interest (ROI) of the human brain. Three types of measures are developed to quantify the
importance of nodes in controlling the brain network: average controllability measures the ability of brain
regions to steer the system state with less energy input; modal controllability identifies brain regions that
steer the system to states which require substantial input energy and boundary controllability identifies brain
regions that locate at boundaries between network communities and control the segregation and integration
of cognitive systems. This study provides a novel perspective to understand the cognitive processes from
the control energy in network control. The proposed methods and measures based on control energy could
provide insights into studies on the controllability of other types of biological networks.
To understand disease etiology from the perspective of network control, Wang et al. [108] defined a concept
called perturbation influence, which is a subset of nodes based on the control paths (vertex-disjoint cycles and
simple paths starting from steering nodes), to identify and quantify the ways by which disease genes perturb
human regulatory networks. Intuitively, for a certain disease, the perturbation influences of different disease
genes can be considered as the significant pathways related to the disease, which are etiologically essential.
In addition, perturbation influence can be applied to prioritize disease genes according to the similarities of
perturbation influences between nodes and known disease genes. Validation of the prioritizing method on 112
diseases shows that this method outperforms the state-of-art method PRINCE [109]. Similar to perturbation
influence, concepts such as control range [110] or vertex domination centrality [111], which are defined based
on control paths as well, have been proposed to study the controllable subspaces of nodes or measure the
importance of nodes in controlling networks. The proposed controllability concepts based on control paths
enrich analytical tools for understanding roles of nodes in controlling network subspaces.
2.6 Conclusion and discussion
In this article, we have reviewed recent advances on the controllability of complex networks and the appli-
cations to biological networks. First, different dynamic models of complex networks were briefly reviewed.
Because of the effectiveness and practicability, we focused on studies which explore the controllability of
complex networks based on linear dynamic model. Then we reviewed algorithms to identify steering node
sets for complete controllability or controlling subspaces. Biological meanings of nodes which play different
roles in controlling biological networks were investigated.
Besides controllability, other concepts in control theory could also shed lights on our ability to understand
or manipulate biological networks, which is worthy for future investigation. For example, observability, which
is a mathematical dual problem of controllability, can be applied to measure the states of biological networks
by monitoring a specific set of biological elements. Other practical constraints such as control trajectories can
be considered in order to avoid some forbidden or fatal states of biological networks during control processes.
It is believed that controlling biological networks will be increasingly feasible and effective when our knowledge
of control theory is enhanced and our understanding of dynamics of biology systems is deepened.
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In the previous chapter, we have reviewed diverse investigations of biomolecular networks from the aspect
of network controllability. Most methods developed to explore the controllability of biomolecular networks
are based on a specific type of steering node set — MDS. However, from the perspective of control theory,
applying independent input control signals to an MDS only satisfies one of two conditions for completely
controlling a network, which does not guarantee the complete controllability of the network. Therefore, it is
reasonable to assume that identifying a more accurate steering node set, which satisfies both conditions of
complete controllability, will benefit our understanding of controllability of biomolecular networks.
In this chapter, a graph-theoretic based algorithm is proposed to identify the MSS of a network while
applying independent input control signals to an MSS is a sufficient and necessary condition to ensure
the complete controllability of the network. Applications to biomolecular networks show that the MSSs in
biomolecular networks are more biologically important than the MDSs in determining the system behaviours.
This chapter accomplishes Objective 2 of this thesis.
Abstract
Many systems of interest in practices can be represented as complex networks. For biological systems,
biomolecules do not perform their functions alone, but interact with each other to form biomolecular networks.
A system is said to be controllable if it can be steered from any initial state to any other final state in finite
time. Network controllability has become essential to study the dynamics of the networks and understand the
importance of individual nodes in the networks. Some interesting biological phenomena have been discovered
in terms of the structural controllability of biomolecular networks. Most current studies investigate the
structural controllability of networks in the context of the minimum driver node sets. In this study, we
analyse the network structural controllability in the context of the minimum steering node sets. We first
develop a graph-theoretic algorithm to identify the minimum steering node set for a given network and
then apply it to several biomolecular networks. Application results show that biomolecules identified in
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the minimum steering node sets play essential roles in corresponding biological processes. The agreement
of the identified steering nodes and existing research results provides a novel perspective for understanding
biological systems. Furthermore, our application results indicate that the minimum steering node sets can
reflect the network dynamics and node importance in controlling the networks better than the minimum
driver nodes sets.
3.1 Introduction
Complex networks are ubiquitous in many scientific subjects. The last decade has witnessed an exceptional
development in understanding the topology and dynamics of complex networks [112–114]. Due to the inter-
actions among nodes in a network, perturbing some nodes can affect other nodes, which may cause the state
transition of a network. Therefore, how to control networks becomes an attractive research topic.
Based on different dynamic models, several methods for controlling networks have been proposed. For
nonlinear dynamic network model, Yang et al. [115] and Cornelius et al. [49] have developed different
strategies to control the states of the networks by perturbing the states of some nodes. For Boolean networks,
the controllability and optimal control have been investigated in [42, 116–118]. The control of linear dynamic
networks attracts a lot of investigations and most of them focus on the controllability of networks. A
dynamic system is completely controllable if the system can be steered from any initial state to any final
state in finite time via suitable inputs. Though the controllability of linear dynamic systems is well studied
by many researchers [19, 119], the criteria such as Kalman’s controllability criterion and PBH criterion
for determination of controllability can not be trivially applied to complex networks due to computational
complexity as well as the unknown or inaccuracy of the parameters [19]. To deal with these limitations, the
concept of structural controllability has been studied [20, 22, 23, 120].
Liu et al. [19] propose a framework to compute the minimum number of independent input control signals
or driver nodes for completely structurally controlling a complex network. Every node in the minimum driver
node set (MDS) is required to be actuated by an independent input control signal in order that the network
is completely structurally controllable. This framework of structural controllability has inspired many recent
studies in the complex network control. On the one hand, some studies extend the structural controllability
framework to different linear dynamic models or different control objectives. For example, Nepusz et al. study
the structural controllability of a switchboard dynamics (SBD) model [57]. Wu et al. propose the structural
transittability of complex networks [56]. Other researchers investigate the output structural controllability
[67, 68] and its applications in drug target identification [67].
Furthermore, several studies investigate control properties of complex networks based on Liu et al.’s
work. The concept such as control centrality [63], control capacity [101] and control profile [107] have been
proposed and studied to discover the controllability of complex networks or investigate the properties of driver
nodes. In addition, the roles of nodes in MDSs of real-world networks, such as biological networks, have been
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investigated [87, 100, 102]. For example, by investigating the roles of driver metabolites in the human liver
metabolic network, Liu and Pan find that the driver metabolites play essential biological functions and the
driver metabolites connecting different pathways are crucial in the controllability of the network. They also
suggest that the environment could be important in health of human liver metabolism since the extracellular
metabolites are critical driver nodes for controlling the network [102]. Liu and Pan analyse the probabilities
of proteins being chosen in an MDS and compare to the roles of proteins played in a human signaling network
[100]. The phenotypic properties and the genetic correlations of the neurons which act as driver nodes in
neuronal network of C.elegans are investigated in [87].
In Liu et al.’s study [19], one driver node is corresponded to one independent input control signal and it
is assumed that one input control signal can also directly actuate on other nodes outsides the MDS in the
network. The node which is actuated by an input control signal is called a steering node. The minimum
steering node set (MSS) consists of the minimum number of nodes which should be actuated by input control
signals in order to have a network structurally controllable. Comparing the definitions between MSS and
MDS, it can be seen that an MSS contains a subset as an MDS. In this study, we focus on the MSSs for
completely structural controllability of complex networks.
The minimum controllability of a network refers to as the cardinality of an MSS to completely control the
network. Olshevsky studies the minimum controllability problem of networks with all known values of exact
parameters by formulating it as the minimum set cover problem [121]. As a result he claim that this problem
is NP-hard. However, Olshevsky [122] has recently investigated the minimum structural controllability and
proposed an algorithm to identifying MSS in polynomial time. In addition, Yin et al. [123] apply the linear
integer programming method to study the minimum structural controllability of networks. In this study, we
develop a novel algorithm which formulates the problem of identifying an MSS as a minimum cost maximum
flow problem, which can be solved in polynomial time. Different from Olshevsky’s algorithm, our developed
algorithm can discover the clear relationship between MDS and MSS, which is important in some applications.
The rest of this paper is organized as follows. Section 2 presents some basic concepts of structural
controllability and compares the MDSs and MSSs. Furthermore, the algorithm to identify MSSs has been
introduced. Section 3 gives results of application examples of real biomolecular networks. Finally, Section 4
concludes this study and points out some directions of future work.
3.2 MSS for structural controllability
It is possible to steer a complex network from a state to another state by the application of input control
signals to some nodes which are called steering nodes. If this can be done at all, there may be many different
ways to do the same tasks. However, it is appealing to identify MSS required to steer a network from any
initial state to any final state. In this section, one algorithm is proposed to identify an MSS in notion of
structural controllability after some basic concepts and results are reviewed.
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3.2.1 Network dynamic model
In this study, we consider the control of complex networks with the linear time-invariant nodal dynamic
model, which can be described by the following equation:
x˙(t) = Ax(t) +Bu(t) (3.1)
where x(t) = (x1(t), ..., xN (t))
T
is a state vector that describes the states of nodes in the complex network. A
is an N ×N state transition matrix which represents the interactions between nodes in the complex network.
aij (i 6= j) in the matrix A indicates the strength of the influence of node j on node i and aii is the sum of
strength of self regulation and intrinsic dynamics, such as degradation, of node i. u(t) = (u1(t), ..., uM (t))
T
is an input vector of M independent input control signals. The N ×M matrix B is an input matrix that
indicates the nodes which are directly actuated by input control signals. The dynamics of a network described
by equation (3.1) is denoted as system (A,B).
3.2.2 Structural controllability conditions
According to the Kalman’s controllability rank condition, system (A,B) is completely controllable if and
only if the N ×NM controllability matrix
C =
[
B AB A2B ... An−1B
]
(3.2)
has the full row rank of N [34].
System (A,B) is called a structural system (A,B) when the entries in matrices (A,B) are either fixed
zero or free parameters. A structural system (A,B) is completely structurally controllable if it is possible
to choose the values for the free entries in matrices A and B such that the Kalman’s controllability rank
condition is satisfied [20].
To study the structural controllability in terms of graph theory, let G(A,B) be a digraph which contains a
set of nodes VA
⋃
VU , where VA = {v1, ..., vn} and VU = {u1, ..., um} and a set of edges vj → vi for aij 6= 0 and
uj → vi for bij 6= 0. G(A) is a subgraph of G(A, B) induced by the node set VA. The nodes in VA correspond
to the state nodes in the network and the edges between them are indicated by the state transition matrix
A. The nodes in VU represent input nodes. Each node ui in VU of G(A,B) corresponds to the input control
signal ui(t) in u(t). Edges from a node ui in VU to nodes in VA correspond to the ith column in the input
matrix B (See Fig. 3.1).
A graph-theoretic condition for structural controllability (Theorem 3.1) has been developed in previous
studies [20, 22, 23, 120]. Before introducing the Theorem 3.1, we define two following concepts which are
illustrated in Fig. 3.2.
Definition 3.1 (Inaccessibility [20]). A node vi in the digraph G(A,B) is called accessible if and only if
there exists a directed path reaching vi from the input vertices VU , otherwise it is inaccessible.
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Figure 3.1: Graph representation of a system. (a): G(A,B) corresponds to system (A,B). (b): The
state transition matrix and input matrix of the system (A,B).
Definition 3.2 (Dilation [20]). The digraph G(A,B) contains a dilation if and only if there is a subset S of
VA such that |T (S)| < |S|. Here, T(S) is the neighborhood set of S containing all nodes vj , that there exists
an oriented edge from vj to a node in S, i.e., T (S) = {vj |(vj → vi) ∈ E(G), vi ∈ S}. E(G) is the edge
set of G(A,B). The input nodes are not allowed to belong to S but may belong to T(S). |S| or |T (S)| is the
cardinality of set S or T(S), respectively.
Theorem 3.1 (Structural controllability theorem [20]). A structural system (A,B) is completely structurally
controllable if and only if:
i) the digraph G(A,B) contains no dilation.
ii) no node in VA is inaccessible from nodes in VU .
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Figure 3.2: Inaccessible nodes and dilation. (a): There is no path from u1 to v2 and v3, therefore
nodes v2 or v3 are inaccessible. (b): Consider a set S = {v2, v3}, we have T (S) = {v1}. Because
|T (S)| < |S|, there exists a dilation.
According to Theorem 3.1, systems corresponding to G(A,B) in Fig. 3.2a and Fig. 3.2b are both struc-
turally uncontrollable.
3.2.3 MDS and MSS
An MDS of a network is a minimum set of nodes to each of which should be actuated by an independent input
control signal to have the network completely structurally controllable. In other words, if a system G(A,B)
is structurally controllable, each node in an MDS of network G(A) should be actuated by a distinct input
node in VU . An MDS can be identified by a maximum matching-based method which has been developed by
Liu et al. [19].
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However, by only applying independent input control signals to each of nodes in an MDS, the resulting
system G(A,B) can not be guaranteed completely structurally controllable. For example, in Fig. 3.3a, the red
edges indicate a maximum matching in G(A), then the MDS is identified to be the nodes without incoming
edges in the maximum matching, which are nodes v1 and v3. By applying two independent input control
signals to v1 and v3, respectively, the resulting system is not completely structurally controllable. It is
because in the G(A,B), nodes v5 and v6 are inaccessible from input nodes u1 or u2 and then the condition
ii) of Theorem 3.1 is not satisfied.
Therefore, to obtain further insights of the controllability of complex networks, we proposed to investigate
the MSSs. An MSS of a network is a minimum set of nodes in which each node should be actuated by an
input control signal to have the network completely structurally controllable. If each of nodes in an MSS
is actuated by an independent input control signal, the resulting system G(A,B) is completely structurally
controllable for sure because both conditions i) and ii) of Theorem 3.1 are satisfied. In the example of Fig.
3.3b, an MSS of the network G(A) is {v1, v3, v5}. By applying each of three independent input control signals
to each node in the MSS, the resulting G(A,B) in Fig. 3.3b is completely structurally controllable.
However, to have a network completely structurally controllable, input control signals actuated on steering
nodes are not necessarily independent. For example, an MSS of G(A) in Fig. 3.3c is {v1, v3, v5}. By
connecting input node u1 to node v1 and v5 and connecting input node u2 to node v3, the resulting system
is completely structurally controllable according to Theorem 3.1. In this case, nodes v1 and v5 are actuated
by a same input control signal from u1, and the network can be controlled by two independent input control
signals.
Actually, from the definitions of MSS and MDS, we can see that each MSS contains an MDS while the
MDS is a maximum subset of the MSS in which each node is connected to a distinct input node in VU .
Therefore, if G(A,B) is completely structurally controllable, each node in the MDS should be connected to
an distinct input node, and the nodes in MSS while not in MDS can be connected to any input nodes. By
only connecting the MDS to the input nodes, the resulting G(A,B) has no dilation but it is not guaranteed
that G(A,B) has no inaccessible node. Connecting nodes in MSS to input nodes ensures that all nodes in
G(A,B) are accessible.
The cardinalities of an MDS and an MSS are denoted as ND and NS , respectively. With the digraph
representation, given a network G(A), since each node in the MDS corresponds to a distinct input node, ND
is the minimum number of input nodes which make up VU such that the structural controllability conditions
can be satisfied. NS is the minimum number of nodes in VA required to be connected to nodes in VU to satisfy
the structural controllability conditions. With the system described by equation 3.1, identifying an MDS
is equivalent to finding a matrix B with the minimum columns such that the system (A,B) is structurally
controllable. Because each column in B corresponds to an independent input control signal, the minimum
number of columns of B is equals to ND. Identifying an MSS is equivalent to finding a matrix B with not
only the minimum number of columns but also the minimum number of nonzero rows such that the system
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Figure 3.3: MDS and MSS. Nodes {v1, v2, v3, v4, v5, v6} and the edges between them make up network
G(A). The red edges indicates a maximum matching of G(A). Node sets {v1, v3} and {v1, v3, v5} are
an MDS and an MSS of G(A), respectively. (a): By applying independent input control signals
to nodes in MDS, the resulting system G(A,B) is not completely structurally controllable. (b): By
applying independent input control signals to nodes in MSS, the resulting system G(A,B) is completely
structurally controllable. (c): The corresponding G(A,B) is completely structurally controllable. The
steering nodes v1 and v5 in the MSS are actuated by a same input control signal from u1.
(A,B) is structurally controllable. Because each nonzero row in B indicates a node in VA which is actuated
by input control signals, the minimum number of nonzero rows of B is equals to NS .
3.2.4 Identification of MSS
Based on Theorem 3.1, Liu et al. map the MDS identification problem to the maximum matching problem
[19]. In fact, the maximum matching can only guarantee the condition i). To identify the steering nodes, the
condition ii) should be satisfied such that all the nodes can be accessible from input nodes.
We formulate the identification of MSS as a minimum cost maximum flow problem in a corresponding
network Gf of a given G(A) [124] (See Fig. 3.4). To construct the network Gf, firstly we compute strongly
connected components (SCCs) of G(A) [125]. If we contract each SCC to a single node, the resulting graph is
a directed acyclic graph. The SCCs that corresponds to nodes without any incoming edge in resulting graph
are called source SCCs. Then Gf can be constructed by the following steps:
1. Construct a bipartite graph which contains node sets R = {r1, · · · , rn} and C = {c1, · · · , cn}. The
nodes ri and ci correspond to the node i of G(A). If there is a directed edge from node i to j in G(A),
there is an edge in the bipartite graph connected rj and ci. The capacity and cost of the edges in the
bipartite graph are one and zero, respectively.
2. Add a sink node t to the bipartite graph and add edges from all nodes in C to the sink node. The
capacity and cost of edges are one and zero, respectively.
3. Add a source node s to the bipartite graph.
4. Let SCC1, SCC2, ..., denote different source SCCs of G(A). For each SCCi that consists of more than
one node, numbering its nodes as SCCi 1, · · · , SCCi j (j > 1):
(a) create three auxiliary nodes aSCCi 1, aSCCi 2 and aSCCi 3
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(b) add an edge from the source to aSCCi 1 with the capacity and cost of the edge being one and zero,
respectively. Add an edge from the source to aSCCi 2 with the capacity and cost of the edge being
j − 1 and zero, respectively. Add an edge from aSCCi 1 to aSCCi 3 with both the capacity and
cost of the edge being one. Add an edge from aSCCi 2 to aSCCi 3 with the capacity and cost of
the edge being j − 1 and zero, respectively.
(c) add edges from aSCCi 3 to each node of {rSCCi 1, · · · , rSCCi j} with the capacity and cost of the
edges being one and zero, respectively.
5. For each source SCCi that consists of only one node SCCi 1, add an edge from the source node to
rSCCi1 with both the capacity and cost of the edge being one.
6. For non-source SCCi that consists of node SCCi 1, · · · , SCCi j, add edges from the source node
to each node of {rSCCi 1, · · · , rSCCi j} with the capacity and cost of the edges being one and zero,
respectively.
We have the following result:
Theorem 3.2. For a minimum cost maximum flow f in Gf, the MSS of the network consists of two types of
nodes:
i) nodes in network whose corresponding nodes in R of Gf without the flow f passing through.
ii) if flow f passes through aSCCi 1, choose an arbitrary node in SCCi as a steering node.
The first type of nodes make up an MDS. To achieve structural control of G(A), each node of first type
should be driven by an independent control, while the second type of nodes can be driven by any one of the
input control signals for the MDS.
Before proving Theorem 3.2, we introduce the concept of power dominating set (PDS) and Lemma 3.1.
Given a network, PDS is defined to be a minimum set of nodes from which all the nodes in the network
can be accessed. By assuming that each node in a network has a self link, Cowan et al. suggest by connecting
only one input control signal to a PDS, the network is completely structural controllable [58]. In fact, by
assuming the existence of self loops in G(A), there is no dilation and thus condition i) of Theorem 3.1 is always
satisfied. In this special case, a matrix B with only one column can always achieve completely structural
control of the networks and the nonzero entries in B are indicated by PDS.
Lemma 3.1. [123] Let MDSb and PDSb denote a pair of MDS and PDS having the biggest intersection,
then MDSb∪PDSb is an MSS.
Proof of Theorem 3.2: It is easy to see that a maximum flow in Gf can be mapped to a maximum matching for
the identification of MDS in the work of Liu et al. [19]. The nodes in R which with a maximum flow passing
through are one-to-one to the matched nodes in the maximum matching. Then the nodes in R without flow
passing through correspond to an MDS and the cardinality of the MDS is ND. For a given G(A), although
it could has many different MDSs, ND is the same.
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Figure 3.4: Identifying an MSS of a complex network by the minimum cost maximum flow method.
(a): G(A) of a complex network and the corresponding system state transition matrix. (b): The
corresponding matrix Gf and the minimum cost maximum flow. The labels represent (flow / capacity;
cost) of the edges. The flow does not pass through r4 and r7, which suggests v4 and v7 make up an
MDS. The flow passes through one edge with cost one, which means there is an additional steering
node which should be chosen from the corresponding source SCC. (c): G(A,B) constructed based on
the flow in graph (b) and system (A,B) is completely structurally controllable. a11 has flow passing
through, then select any one node in corresponding source SCC as additional steering node. Here v1
has been selected, and the MSS is identified as {v1, v4, v7}. (d): The designed matrix B for having the
complex network completely structurally controllable.
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Considering the cost of a maximum flow in Gf, the cost c of the flow equals to the number of nodes aSCCi 1
which have the flow passing through, which is equal to the number of source SCCs that have no node in the
MDS identified by the maximum flow. Denote PDSsub as a set of nodes by arbitrarily choosing one node
from each SCCi whose corresponding aSCCi 1 have the flow passing through. Then we have |PDSsub| = c
and PDSsub = PDS− (PDS∩MDS). Therefore, it is not difficult to find out that |MDS∩PDS| = NP −c.
Since the value of NP does not change with PDS for G(A), we have |MDS ∩ PDS|max = NP − cmin.
For a minimum cost maximum flow in Gf, the cost c is minimum and the corresponding MDS and PDS
are a pair MDSb and PDSb. According to Lemma 3.1, the theorem is proved (See Fig.3.5).
MDS PDS
PDSsub 
Network node set 
Figure 3.5: Illustration of node sets and their cardinalities. The cardinalities of MDS and PDS are
ND and NP respectively, which are constants for given G(A). The cardinality of PDSsub is c, which is
the cost of a maximum flow in Gf. The cardinality of a union of any pair of MDS and PDS is equal to
ND + c, so the cardinality of an MSS is ND + cmin.
3.2.5 Algorithm implementation and complexity analysis
The minimum cost maximum flow problem can be solved in O(|f |m log n) time, where |f | is the amount
of the flow [73]. In this study, since the Gf is specifically constructed, we can combine the Hopcroft-Karp
algorithm [71] and Ford-Fulkerson algorithm [73]. The combined algorithm can solve the MSS problem with
a time complexity of O(N1/2L+L∗NsSCCb) in the worst case, where N , L and NsSCCb represent the number
of nodes, edges and the number of source SCCs which has more than one node, respectively.
According to [73], if f is a minimum-cost flow and f ′ is a flow by augmenting f along an augmenting
path pi with the minimum cost, then flow f ′ is a minimum-cost flow. Notice that the cost of flow on each
edge is either 0 or 1, then according to the theorem in [73], finding a minimum cost maximum flow in Gf can
be divided into three steps:
1. We consider a flow f1 of Gf such that for each source SCC, there is at least one node in corresponding R
which has no flow passing through. f1 can be obtained by finding a maximum matching in a bipartite
graph Gbi. Gbi is an induced subgraph of Gf which contains all the nodes in C and R
′. R′ is a subset
of R. For each source SCC, by arbitrarily removing one node in R corresponding to the source SCC,
the rest of nodes in R consist of R′. If a source SCC has only one node, remove the only node in R
corresponding to this source SCC.
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A maximum matching in Gbi is one-to-one to an eligible f1 in Gf. Since all the edges that f1 passes
through the cost zero, f1 is a minimum-cost flow. We denote the value of flow f1 as vf1, which equals
to the number of matched nodes in set R in the maximum matching of Gbi. (Figure S3.6)
2. Based on the flow f1, iteratively find an augmenting path from the source to the target with the cost
of 0 and augment to the current flow. Until the iteration stops, the current flow is denoted as f2 and
the value is denoted as vf2.
3. Based on the flow f2, iteratively find an augmenting path from the source to the target and augment
to the current flow. Until the iteration stops, the current flow is denoted as f3 and the value is denoted
as vf3. Then f3 is a minimum cost maximum flow, the value of the flow is vf3 and the cost is vf3−vf2.
Since it is known that the NS is equal to ND + cost, and we have ND = N − vf3 and cost = vf3 − vf2,
then we have NS equals to N−vf2. Therefore, to calculate the NS of a network, only the first two steps need
to be operated. To further identify the MDS which is a subset of MSS, the step 3 can be performed. The
step 1 can be solved by Hopcroft-Karp algorithm in time O(N1/2L). Augmenting procedures in steps 2 and
3 can be solved by Ford-Fulkerson algorithm. Each augmenting path can be found in O(L) and the iterations
number will be no more than NsSCCb. Generally NsSCCb  N , then the time complexity is reduced to
O(N1/2L).
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Figure 3.6: Step 1 of finding minimum cost maximum flow. (a): A corresponding Gbi and a maximum
matching. Red edges represent the maximum matching. (b): The flow f1 corresponds to the maximum
matching in (a). Red edges represent the flow f1.
3.3 Application results
We employ several different biological systems to demonstrate the differences between MDS and MSS. We
discover that MSS is more feasible for investigating the structural controllability of real networks comparing
to MDS. These examples are cell cycle networks of budding yeast [11] and fission yeast [13], Epithelial to
Mesenchymal Transition (EMT) network [91] and myeloid differentiation regulatory network [37].
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3.3.1 Yeast cell cycle network
The cell-cycle is a vital biological process in which the division and duplication of a cell takes place to produce
its two daughter cells. For the budding yeast, Li et al. [11] have established a molecular network model for cell
cycle of S. cerevisiae. For the fission yeast, Davidich et al. [13] have established a molecular network model
for cell cycle of S. pombe. Applying the logic-like operations, the evolution of molecule states in different
phases of cell cycles can be modeled. Sequences of molecule states can be observed which exactly matches the
corresponding biological time sequences of cell cycles, from the excited G1 state (START) through S and G2
to the M phase and finally arrive at the G1 state of next cycle. For both S. cerevisiae and S. pombe models,
the attractors with the largest basin size correspond to the G1 stationary states. In this study, we apply
the structural controllability to analyze these two networks. For structural controllability, only regulatory
relationships between molecules are required, then we study on the networks by considering both activation
and inhibition edges of two original networks as simple directed edges (See Fig. 3.7).
S. cerevisiae network:
The S. cerevisiae network consists of 11 essential molecules with 34 interactions as shown in Fig. 3.7a. We
apply our method to the network and find that the minimum number of steering nodes is 1 and there is
a unique MSS which consists of Cln3. This result indicates that by applying input control signal to Cln3,
the network is completely controllable. In fact, the Cln3 is critical in starting the cell cycle of S. cerevisiae.
When Cln3 is activated by external signals, signal cascades will be triggered in the network which induce the
subsequent cell-cycle phases [11]. This biological observation is in agreement with the importance of Cln3
for the control of the cell-cycle network.
For MDS, by applying the method in [19] to the cell-cycle network, the minimum number of driver nodes
is also 1 which could be Cln3, MBF or SBF. However, by only applying input control signal to either MBF or
SBF this network cannot be completely controlled because neither of them regulate node Cln3. Therefore, one
can conclude that MSS is more feasible than MDS in investigating the controllability of complex networks.
S. pombe:
The S. pombe network consists of 9 essential molecules with 26 interactions as shown in Fig. 3.7b. Applying
the maximum matching method and our algorithm, we can identify the ND and NS for this networks are both
2. There are 20 different sets of MDSs, however, by only applying input control signals to different MDSs,
the resulting system is not always structurally controllable. Among these sets of MDSs, 6 different sets are
also MSSs, which can be represented as {SK, v}, where v ∈ {Ste9, Rum1, Cdc25,Wee1/Mik1, Slp1, PP}.
Note that all the MSSs contains node SK, because there is no directed edge from other nodes to SK, then SK
should be actuated in order to have the network completely structurally controllable. According to the model
of [13], the SK represents start kinases, which is a set of kinases (such as Cdc2/Cig2) that can be activated
40
by cell mass. SK can inhibit Ste9 and Rum1, which starts the cell-cycle process. Therefore, the fact that SK
has been identified in all sets of MSSs is in agreement with the critical role that SK plays in starting a cell
cycle. Besides SK, one additional node should be chosen as a steering node to form an MSS. We find that
the additional node can be arbitrarily chosen in the network excepts Cdc2/Cdc13 and Cdc2/Cdc13*. In the
cell cycle, concentrations of Cdc2/Cdc13 or Cdc2/Cdc13* vary during each phase transitions, which indicates
the Cdc2/Cdc13 and its unphosphorylated form Cdc2/Cdc13* are essential [13]. No MSS contains these two
nodes suggests that the steering nodes avoid essential nodes. Actually, these two nodes have highest degrees
in the network, which suggests that steering nodes also avoid hub nodes as driver nodes discussed in [19].
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Figure 3.7: Cell-cycle network. (a): S. cerevisiae cell-cycle network. (b): S. pombe cell-cycle network.
3.3.2 EMT network
During the EMT process, cells change their genetic and trancriptomic program leading to phenotypic and
functional alteration and this transition starts the metastatic dissemination [91]. To study EMT, Moes
et al. [91] have constructed an EMT network which consists of 6 nodes and 15 interactions (Fig. 3.8).
For this network, all 6 nodes are significantly differentially expressed between epithelial and mesenchymal
phenotypes. Applying our algorithm, we can identify the NS equals to 1 and node SNAI1 makes up an MSS.
This result is consistent with the experimental result verified by Moes et al. [91] that SNAI1 can activate the
transition from epithelial to mesenchymal phenotype. Besides SNAI1, we find that any node excepts CDH1
can make up an MSS of the network, too. According to the literature [91], SNAI1, MIR203 and MIR200
are key regulators of epithelial homeostasis, which also supports the ability of these nodes for controlling the
network. While other two identified MSSs which consist of ZEB2 and ZEB1 respectively are deserved for the
further investigation. When the maximum matching method is applied to this network, anyone of six nodes
could be an MDS. However, applying input control signals to CDH1 cannot control the whole network as
CDH1 does not regulate any other nodes in the network.
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Figure 3.8: The EMT network.
3.3.3 Myeloid differentiation regulatory network
Common myeloid progenitor (CMP) is a cell state which can proliferate and differentiate into megakaryocyte-
erythrocyte progenitors (MEP) and granulocyte-monocyte progenitors (GMP). The MEP and GMP could
further give rise to megakaryocytes, erythrocytes, granulocytes, monocytes and others. To study these
processes, Krumsiek et al. [37] have constructed a myeloid differentiation regulatory model network which
consists of 11 transcription factors and 27 regulatory interactions (Fig 3.9). We apply our method to the
network and find that the minimum number of steering nodes is 1. The MSS is unique which consists of
C\EBPα. The result suggests that by applying input control signal to C\EBPα, the network is completely
controllable. According to previous studies [37, 126], C\EBPα is known to be essential for development of
GMP. In addition, it is known that C\EBPα is a key regulator of early myeloid development [127] as well
as in hematopoietic stem cells [126]. The existing research results support the potential of C\EBPα for
controlling the whole network. The minimum number of driver nodes of this network is also 1 and yet an
MDS could be a set which consists of any one of C\EBPα, GATA-1, FOG-1, PU.1, EKLF and SCL. However,
by only applying input control signal to any one of GATA-1, FOG-1, PU.1, EKLF and SCL, this network
cannot be completely controlled since C\EBPα is not regulated by other nodes. Comparing to other nodes
in MDSs, C\EBPα plays more important role in controlling the whole network and the cell proliferation and
differentiation process. Therefore, the identification of MSS is more feasible than MDS in investigating the
controllability of complex networks.
3.4 Conclusion
In this work, we developed an efficient algorithm to calculate the NS and the MSSs for completely structural
controllability of complex networks. By transferring the minimum control problem into a minimum cost
maximum flow problem, our approach can be interpreted meaningfully. Maximizing the flow guarantees the
number of driver nodes is the minimum, while the number of steering nodes required besides the driver nodes
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Figure 3.9: A regulatory network of myeloid differentiation.
is minimized by minimizing the maximum flow cost. Though there is a standard algorithm to solve the
minimum cost maximum flow problem, our algorithm has been optimized for this particular problem.
Since only applying input control signals to MDS can not guarantee the completely structural controlla-
bility, in the realization of control strategies, identifying steering nodes is inevitable, and we always have to
know which nodes should be actuated. Furthermore, we apply our method to four biological networks, the
results suggest that it is more meaningful by using MSSs to investigate structural controllability of complex
networks comparing to MDSs.
Taking together, our study is a supplement to the controllability of complex networks. The application
results suggest that the identified steering nodes in MSSs of biomolecular networks indeed play importance
roles in controlling the states of the networks. In the future, the further properties of NS should be in-
vestigated and MSSs would be applied to biomolecular networks that control pathogenesis for drug target
identification. In addition, this study only focuses on the controllability of networks while the inputs u and
control time are not taken into consideration. Therefore, input control signal design for optimally controlling
network could be one direction of our future work for practical applications.
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In the previous chapter, an algorithm was proposed to identify the MSS for complete controllability of a
biomolecular network. Nodes in the MSS have important biological functions. However, the MSS only reflects
complete controllability, which is the controllability of the whole network. In many situations, controlling a
portion of nodes instead of the whole network is more practical.
In this chapter, controllability of a subset of nodes is formulated as the problem of network output
controllability. An algorithm is developed to identify steering nodes for output controllability of a network.
The method can be used to identify drug targets based on biomolecular networks: disease related biomolecules
correspond to a subset of nodes which can be controlled while the identified steering nodes are potential drug
targets. This chapter fulfills Objective 3 of this thesis.
Abstract
Biomolecules do not perform their functions alone, but interactively with one another to form biomolecular
networks. It is well known that a complex disease stems from the malfunctions of corresponding biomolecular
networks. Therefore, one important task is to identify drug targets from biomolecular networks. In this study,
drug target identification is formulated as a problem of finding steering nodes in biomolecular networks while
the concept of network output controllability is applied to the problem of drug target identification. By
applying control signals to these steering nodes, the biomolecular networks are expected to be transited
from one state to another. A graph-theoretic algorithm is proposed to find a minimum set of steering nodes
in biomolecular networks which can be a potential set of drug targets. Application results of the method
to real biomolecular networks show that identified potential drug targets are in agreement with existing
research results. This indicates that the method can generate testable predictions and provide insights into
experimental design of drug discovery.
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4.1 Introduction
The last decade has witnessed the exceptional development in biomolecular interaction data and most at-
tention has been paid to biomolecular networks [128]. Cellular systems can be represented as biomolecular
networks which are graphs consisting of nodes and edges. According to various levels of interactions between
biomolecules, there are different types of biomolecular networks in cellular systems. For example, gene reg-
ulatory networks (GRNs), metabolic networks and protein and protein interaction (PPI) networks represent
the directed or undirected interactions between biomolecules [129].
Network science is an interdisciplinary academic field that investigates the topology and dynamics of
complex networks [102, 130]. The network studies have become powerful tools in the field of biology to
discover the properties and understand the functions of biological systems. For example, network centralities
are quantitative indices for assessing the position of a node relative to the other nodes, and have been
used to elucidate the functional roles of components in different biomolecular networks [129]. Studies have
revealed that the centralities of biomolecules correlate with their essentialities and many researchers have used
centralities to distinguish essential components (i.e. essential proteins) or reactions in biomolecular networks
[131–135]. In addition, many other network-based methods can be applied to understand biological systems,
such as network clustering, which has been used to detect functional modules in PPI networks [9, 136, 137],
and network alignment, which has been used to query a subnetwork or pathway that was previously known
to be functional modules from a given large network or database [138].
For the problem of drug target identification, the single-target approach in drug discovery was dominant
for a long time [139]. However, there are many limitations for drug design against single-target in the aspects
of drug efficiency and safety. For the aspect of efficiency, drugs in clinical treatment may not be as efficient as
predicted in the experiment because of the interactions between pathways in biomolecular networks. Many
biomolecular networks are robust so that the change of a single target would be offset by the interactions in
the networks, which makes the phenotypes of the biological systems unchanged [140]. On the other hand,
side effects often come from the undesired effects of drugs on the biomolecular networks. A single-target drug
may affect the states of non-target biomolecules and cause unexpected effects that can not be eliminated.
To overcome the weaknesses of single-target drugs, multi-target drug design has attracted growing attention
in recent years. Systems biology, which uses network-based approaches to study biomolecular networks as
whole systems, plays a vital role in drug design [128, 141, 142].
Past studies have made great progresses in discovering disease-related information based on network
approaches, such as identification of disease biomolecules and drug targets. Several network-based methods
have been developed to identify disease biomolecules, including linkage-based, module-based, diffusion-based,
and Markov random field-based methods [109, 142–146]. These approaches are based on different assumptions
on the properties that disease biomolecules may have in biomolecular networks. For example, the linkage-
based method tends to associate a protein with a disease if its directly interacted proteins relate to the
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disease [143]. By this method, Janus kinase 3 (JAK3) has been correctly predicted to involve in combined
immunodeficiency syndrome.
Drug targets are combinations of biomolecules in the networks and by changing their states biomolecular
networks in abnormal states can be driven to healthy ones. To identify drug targets, some approaches which
focus on the topology of biomolecular networks have been proposed. Csermely et al. [140] introduce a
network-based method for identifying multi-target drug identification. Hwang et al. [147] propose a concept
named bridging centrality for each node and suggest that the biomolecules with high bridging centralities
are potential drug targets. Besides the studies which only focused on the static topological properties of
biomolecular networks, there are other approaches based on the dynamics of biomolecular networks. These
approaches are based on different dynamic models of biomolecular networks and intend to change the states
of biomolecular networks by directly affecting the states of identified drug targets. In the dynamic-based
approaches, the state changes of disease or non-disease biomolecules are considered as drug efficiency or
toxicity. Yang et al. [115] construct an arachidonic acid metabolic network (AAnetwork) in which all the
interactions between biomolecules are expressed by ordinary differential equations. Based on the model,
not only have optimal target sets been identified, but also mechanisms for the side effects of existing drugs
NSAIDs and Vioxx have been found. Li et al. [15, 16] use a flux balance analysis based linear program model
to discover drug targets, which does not require much detailed knowledge of network dynamics compared to
Yang’s method. Wu et al. [148] develop a network dynamic model to identify effective drug combinations
and successfully detect the combination of Metformin and Rosiglitazone, which is actually Avandamet, an
effective drug to cure Type 2 diabetes.
The control of networks is a central issue in network science [19, 102]. Several researchers have applied
network control strategies to the identification of drug target sets in biomolecular networks. In the view
of control theory, drug targets in biomolecular networks can be interpreted as steering nodes. By applying
signals to the set of steering nodes the networks are expected to be steered to desired states. Based on the
Boolean networks model, Kim et al. [42] apply the genetic algorithm to search for a minimum steering node
set. Based on nonlinear dynamic network model, Cornelius et al. [49] study the T-cell survival signalling
network that governs the development of T-LGL leukemia and rank the nodes according to their potential
to be steering nodes.
In this study, we apply the concept of structural controllability [19, 20, 22, 24] to the problem of drug target
identification. The definition was firstly proposed by Lin in 1974 and several researchers generalized Lin’s
result or proved it using different methods [22, 23, 120]. The structural controllability only concerns whether
there are interactions between nodes in a network and does not consider the strength of the interactions.
Liu et al. apply the theory of structural controllability to different types of real networks and determine
the minimum set of so-called driver nodes, to which applied by input signals, the networks can be driven to
any desired state in finite time [19]. Wu et al. [56] study the structural transittability of complex networks.
Unlike the complete controllability which concerns the ability of a system that transits from any state to any
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other state, transittability concerns the ability of the system that transits between two specific states. To
steer a system from an abnormal state to a healthy state, using the transittability needs less steering nodes
and has smaller state space affected than complete controllability. Instead of focusing on nodal dynamic
model, Nepusz et al. [57] propose an edge dynamic model, which has been called the switchboard dynamics
(SBD), and the controllability of networks with SBD has been studied. In addition, based on the structural
controllability, Liu and Pan investigate the roles of driver metabolites in the human liver metabolic network
and suggest such metabolites play essential biological functions [102].
In this study, we present a new drug target identification method based on the structural output con-
trollability of complex networks. Section II presents the formulation of drug target identification and the
algorithm to find out the minimum set of steering nodes which are potential drug targets. Section III gives
results of verification experiments on real biomolecular networks. Finally, section IV concludes this study
and points out some directions of future work.
4.2 Problem Formulation
If a system is completely controllable, it can be steered from any state to any other state via appropriate
inputs. For a biological system at an abnormal state, if perturbing some biomolecules can affect other
biomolecules and steer the system to a healthy state, these perturbed biomolecules can be considered as drug
targets. Thus the problem of identifying drug targets can be formulated as the problem of finding sets of
steering nodes in systems. By applying the control signals to these nodes, the systems can be steered from
undesired states to other desired states.
4.2.1 Dynamic model of biomolecular networks
Even though complex dynamic processes are nonlinear, the controllability of nonlinear systems is structurally
similar to that of linear systems in many aspects [19, 149]. Actually, to ultimately develop the control strate-
gies for complex nonlinear networks, a necessary and fundamental step is to investigate the controllability
(especially structural controllability) of complex networks with linear dynamics [56]. The drug target iden-
tification based on the structural controllability can provide a preliminary understanding of potential drug
targets. In this study, we use the linear time-invariant nodal dynamic model, which is the most popular and
canonical model, to represent the dynamics of a biomolecular network with n nodes:
x˙(t) = Ax(t) +Bu(t) (4.1)
where x(t) = (x1(t), ..., xn(t))
T
is a state vector that describes the states of nodes in the biomolecular network.
From the perspective of a biomolecular network, states of nodes can be concentrations of metabolites or
enzymes in a metabolic network or can be expression levels of genes in a gene regulatory network. A is
an n × n state transition matrix which represents the interactions between nodes (biomolecules) in the
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biomolecular network. Each entry aij in the matrix A indicates the strength of the influence of biomolecule
j on biomolecule i. The n ×m matrix B is an input matrix that corresponds to the steering nodes and bij
indicates the strength of an external input j to biomolecule i in the network. u(t) = (u1(t), ..., um(t))
T
is an
input vector of m external inputs and each external input corresponds to a column in B. External inputs to
the biomolecular network can be considered as different types of stimuli to the network, such as environment
effects and drugs. In this study, we only consider drugs as external inputs which are control signals.
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Figure 4.1: (a): A graphic representation of a system. (b): The corresponding matrices (A,B) of
the system.
We use matrix pair (A,B) to represent the system described by equation (4.1). A system with matrices
(A,B) can be represented as digraph G(A,B). G(A,B) is a digraph which contains sets of nodes VA
⋃
VU ,
where VA = {v1, ..., vn} and VU = {u1, ..., um}. The edge set is the pairs vj → vi for aij 6= 0 and uj →
vi for bij 6= 0. The nodes in VA and the edges between them make up the biomolecular network. The nodes
in VU represent input nodes. Edges from a node ui in VU to nodes in VA correspond to a column in the input
matrix B. Fig 4.1 shows an example of the graphic representation.
4.2.2 Completely structural controllability and structural output controllability
Suppose the control signals u can be chosen arbitrarily, input matrix B should be well designed in order to
steer a biomolecular network from an abnormal state to a healthy state. Finding drug targets becomes the
problem of finding an input matrix B. To measure the ability of steering the networks to healthy states, the
concept of controllability has been used.
In control theory, a system is completely controllable if for any initial state x(t0) = x0 and any other
final state x1, there exists a finite time tf and inputs u(t), such that x(tf ) = x1 [149, 150]. According
to the Kalman’s controllability rank condition, system (4.1) is completely controllable if and only if the
controllability matrix
C =
[
B AB A2B ... An−1B
]
(4.2)
has full row rank n [34]. To completely control a system, the matrix B should be properly designed to satisfy
the Kalman’s condition, which is equivalent to find an appropriate set of steering nodes in the network.
However, there are too many nodes that control signals should be applied to in order to make a biomolec-
ular network completely controllable. Specifically, in gene regulatory networks, independent control signals
should directly apply to at least about 80% of nodes to completely control the networks [19]. For the drug
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target identification problem, it is difficult and unnecessary to completely control the networks. In reality, we
more concern about the states of the nodes that will relate to diseases or side effects. So we take the states
of disease biomolecules and side effects causing biomolecules into consideration. The output controllability
of networks can measure the controllability of a set of nodes in the networks, which motivates us to study
the output controllability of biomolecular networks in this study.
The outputs of a network (A,B) can be expressed by the following equation:
y(t) = Cx(t) (4.3)
where y(t) = (y1(t), ..., yp(t))
T
is an output vector of the network and each entry represents an output. The
outputs of the network are linear combinations of node states in the networks represented by the p×n matrix
C. In this research, we assume that for the output matrix C, there is one and only one entry which has
nonzero value in each row of C while other entries are zero, and the nonzero entries are in different columns.
With this assumption, each entry in y(t) represents the state of one node that is indicated by a corresponding
row of C. The outputs y(t) are the states of a set of biomolecules in the biomolecular network. A system
described by equations (4.1) and (4.3) is denoted by matrix triplet (A,B,C).
A system is output controllable if for any initial output vector y0 = y(t0) and any other final output
vector y1, there exists a finite time tf and inputs u(t), such that y(tf ) = y1. For a dynamic system model
described by equations (4.1) and (4.3), the p×mn output controllability matrix is defined as:
oC =
[
CB CAB CA2B ... CAn−1B
]
. (4.4)
Based on the control theory, system (A,B,C) is output controllable if and only if rank (oC) = p [69].
In the problem of drug target identification, we concern about the states of the disease biomolecules
as well as the biomolecules whose state changes would lead to side effects. The objective of drug design
is to make the states of disease biomolecules healthy while keeping the state changes of side effect-causing
biomolecules minimal. So we consider the outputs of the biomolecular networks are the states of these two
types of biomolecules, which determine the output matrix C. For a biomolecular network represented by
matrix A and the output matrix C has been identified by the specific nodes, the problem of drug target
identification can be formulated as finding a matrix B that makes the system (A,B,C) output controllable.
Fig. 4.2 shows the framework of the drug target identification process.
Though the rank of matrix C (oC) can judge whether a system is completely (output) controllable, it is
difficult to calculate the rank directly. When n becomes large, the calculation of the rank of C would be
time consuming and hardly be accurate. In addition, for most biomolecular networks, we often only know
whether there is an interaction between two biomolecules, but don’t know the strength of the interaction
between them. So we can only judge whether an entry in matrix A is zero or not. A matrix is said to be
a structural matrix if its entries are either fixed zeros or independent free parameters. System (A,B,C) is
called a structural system if A, B and C are structural matrices. “Structural controllability” is a concept
which measures the controllability of structural systems [20].
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Figure 4.2: Framework of the method. The right blocks illustrate the processes of drug target
identification and left blocks indicate the knowledge needed.
For a structural system (A,B), the dimension (rank of controllability matrix C) of its controllable subspace
varies as a function of free parameters in matrices A and B. By arbitrarily choosing the value of free
parameters in A and B, the dimension of controllable space of structural system (A,B) can reach a maximum
value. We define the maximum value as the generic dimension of the controllable subspace of structural
system (A,B) and denote it by GDCS(A,B) [56]. Similarly, the maximum value of rank of oC achieved
by arbitrarily choosing the free parameters is defined as the generic dimension of the controllable output
subspace of structural system (A,B,C) and denoted by GDCOS(A,B,C). A structural system (A,B,C)
is called completely structurally controllable if GDCS(A,B) = n and structurally output controllable if
GDCOS(A,B,C) = p.
To analyze the completely structural controllability, a graph-theoretic method has been proposed to
calculate the GDCS(A,B) [22]. In a graph, a sequence of edges {(v1 → v2), (v2 → v3), ..., (vk−1 → vk)} is
called a simple path if all the nodes {v1, v2, ..., vk} are distinct. If v1 = vk and other nodes are distinct, the
path is called a simple cycle. A node vi in VA is called inaccessible from input nodes if and only if there
are no paths that can reach it from nodes in VU . To illustrate the graph-theoretic method, we define a path
and cycle covering to be a set of simple paths starting from input nodes in VU and simple cycles that are
accessible from input nodes where all the paths and cycles have no nodes in common.
In digraph G(A,B) of a structural system (A,B), the value of GDCS(A,B) is equal to the maximum
number of nodes in VA that can be covered by a path and cycle covering [20, 22]. Based on this result, Liu
et al. use a maximum matching algorithm to find out a set of VU that has the minimum number of nodes,
which is equivalent to, construct a structural matrix B that has the minimum number of columns, to make
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the system (A,B) completely structurally controllable [19].
However, the GDCOS(A,B,C) can not be calculated accurately by any graph-theoretic method yet.
Murota and Poljak [24] have developed a method to calculate the upper and lower bounds ofGDCOS(A,B,C).
In this study, to make sure the designed matrix B can make the system structurally output controllable, we
use the lower bound. Based on our assumption, each row in C corresponds to one node in the biomolecular
network which is a node in VA. p rows of C correspond to p different nodes which is a subset of VA and
denoted as VO. Notice that if every node state is considered as an output, the output controllability reduces
to the complete controllability. According to [24], the lower bound of GDCOS(A,B,C) is the maximum
number of nodes in VO that can be covered by a path and cycle covering in G (A,B). Similar to Liu et al. [19]
whose work is to find a matrix B that makes the system completely structurally controllable, we study the
structural output controllability of complex networks and apply it to identify drug targets from biomolecular
networks. We develop a new algorithm to identify a minimum steering node set (drug targets) needed to
control the outputs of the system based on the calculation of the lower bound of GDCOS(A,B,C).
4.2.3 Method description
Given a biomolecular network whose structural matrices A and C have been determined, we would like to
develop an algorithm to find a matrix B which makes the GDCOS(A,B,C) equal to p. Since we expect
less biomolecules to be drug targets for certain disease, which makes more feasible for drug production,
the algorithm should be designed to minimize the number of steering nodes. In addition, the GDCS(A,B)
measures the dimension of controllable subspace of the structural system. The smaller value of GDCS(A,B),
the lower dimension of state space will be affected, and thus the less chance there are side effects [56]. Then
the matrix B identified by the algorithm should ensure the structural output controllability of the system and
try to make GDCS(A,B) small. Since there is no algorithm to calculate the GDCOS(A,B,C) accurately,
the developed algorithm makes sure the lower bound of GDCOS(A,B,C) equals to p, which guarantees that
the system is structurally output controllable. In this study, we assume that each column in B contains one
and only one nonzero entry, which means if we choose a node as a drug target, the node can be controlled
independently. In graph-theoretic representation, every node ui ∈ VU , i = 1, ..,m can connect with one and
only one node vj ∈ VA, j = 1, ..., n.
Firstly we construct a weighted bipartite graph that corresponds one on one to the network A and the
output C. Nodes ri ∈ VR and cj ∈ VC in the bipartite graph correspond to row i and column j of matrix A,
respectively. S ⊆ VA denotes the set of nodes within which the drug targets will be selected and VS ⊆ VR
denotes corresponding nodes of S in VR. For example, we can select a set of nodes which represent enzymes
in a metabolic network as set S. There are k candidate input nodes u′i ∈ VU ′ and each u′i connects to a
distinct node in VS , where k is the number of nodes in VS and VU ′ denotes the candidate input node set in
the bipartite graph.
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The edges and the weights of the bipartite graph are defined as follows:
wricj =
1 aij 6= 0 and vi ∈ VO0 (aij 6= 0 or aij = 0, i = j) and vi /∈ VO (4.5)
and for every rsi ∈ VS , where si indicates that the ith node in VS is the sith node in VR, there are edges
wrsiu
′
i
=
ε× rccsi vsi ∈ VOε× rccsi − 1 vsi /∈ VO (4.6)
where rccsi ∈ {1, 2, ..., n} is the ranking of control centrality of node vsi in G(A,B) [63], the node with largest
control centrality has rccsi = 1. ε is an arbitrarily small positive number and less than 2/k(k + 1) for a
network with k nodes in S. Therefore we can ensure that for the score any maximum weight matching, the
sum of terms that containing ε is less than 1. For simplicity, ε can take the value of 0.001, 0.0001, 0.00001
or the like.
Then we use Kuhn-Munkres (KM) algorithm to find out the maximum weight complete matching of the
constructed bipartite graph [151]. The maximum weight complete matching means every node in VR has been
matched to a distinct node in VC or V
′
U while the sum of the weights of edges in the matching is maximum.
Each node in VR that matches a node in V
′
U is considered as a steering node in the corresponding digraph
and can be regarded as a potential drug target.
If there is no complete matching for the constructed bipartite graph, the KM algorithm will not work.
This means system is not able to be output controllable with the steering nodes chosen from set S and the
drug target combination can not be found in the S by our method.
A complete matching of the bipartite graph corresponds to a covering consisting of simple paths starting
from input nodes and cycles that covers all the nodes in VO. If ri matches ci and wrici is zero, node vi would
be a node uncovered by the covering in G(A,B). If ri matches cj(i 6= j) or i = j while wrici = 1 in the
complete matching, there is an edge from vj to vi in the covering. For vi ∈ VO, if aii = 0, there is no edge
between ri and ci in the corresponding bipartite graph, then ri can not match ci and vi must be covered by
the corresponding covering. If rsi matches a node in V
′
U , vsi is a steering node which is directly connected
to an input node in the corresponding G(A,B).
It can be proved that the number of nodes in VR matched in V
′
U is minimum (see Section 4.5), which
minimizes the number of steering nodes. Control centrality measures the controllable subspace of a node vi
as steering node [63]. It is equal to the GDCS(A, b), where b is a column vector and the only non-zero entry
is the ith one. To reduce the GDCS(A,B), the node vsi with small control centrality has large rccsi and
therefore has high priority to be matched in a maximum weight matching. Though priority of nodes to be
steering nodes does not ensure the GDCS(A,B) minimum, a node with smaller control centrality is more
likely to be considered as a steering node, which reduces the GDCS(A,B) in many cases.
After the maximum weight matching, we search for all the nodes in VO covered by cycles and then
check whether if all these cycles are accessible from input nodes. If so, the covering is a path and cycle
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covering. Otherwise, we can add more input nodes to make the inaccessible cycles which contain nodes in
VO accessible from input nodes. This can be accomplished by a graph searching algorithm based on strong
connected components (SCCs) identification. We choose some nodes from higher hierarchy SCCs as drug
targets to make all cycles which contain nodes in VO accessible from input nodes [58, 63], which guarantees
that the system is structurally output controllable.
Fig. 4.3 is an illustrative application of the proposed method to the biomolecular network.
D
F
E
»»»¼
º«««¬
ª
 
»»»»»»»»¼
º««««««««¬
ª
 
0*0000
00*000
0000*0
, C
0*0000
*000*0
0000*0
0000*0
* 0 0 0 0 0
000000
A
G H
u'4
u'5
u'6
u'1
u'2
u'3
C6
C3
C1
C5
C4
C2
R1
R2
R3
R5
R6
R4
R1
R2
R3
R6
R4
R5
u'6
u'5
u'4
u'3
u'2
u'1
C6
C5
C1
C3
C2
C4
u1
v4
v1
v5v3 v2 v6
v6
v1
v4
v3 v2 v5
Figure 4.3: An illustrative example. (a): A biomolecular network. The outputs of the system are
the states of tinted nodes. (b): Step 1, construct a corresponding structural matrix A of biomolecular
network in Fig. 4.1. By assuming that v2 and v5 are related to a certain disease and the abnormality
of v4 will cause serious side effects, construct the corresponding structural matrix C as step 2. “∗” in
matrices A and C represents the free parameters while “0” represents the fixed parameters. (c): Step
3, the weighted bipartite graph. The weights of dot lines, dash lines, dash dot lines and solid lines
are 1, 0, ε× rccsi and ε× rccsi − 1, respectively. (d): Step 4, one of the maximum matching results.
(e): Simple path and cycle in original graph corresponds to d). Because the cycle v5 → v6 → v5 is
accessible from drug target node v2, no more drug targets node needed. The identified drug target is
node v2.
4.3 Results
We employ several biomolecular networks with different phenotypes or disease states in order to demonstrate
the applicability and feasibility of our method.
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4.3.1 Results from drug discovery-relevant human networks
AAnetwork: The AAnetwork (arachidonic acid metabolic network) is an inflammation-related work model
constructed by Yang et al. [115]. Inflammation is a protective attempt by the organism to harmful stimuli,
such as pathogens, damaged cells, or irritants. Inflammation mediators are chemical substances which cause or
participate in inflammation. Some metabolites such as COX-2 and 5-LOX which play key roles in generating
inflammation mediators are considered as typical drug targets. However, single-target anti-inflammation
drugs always have side effects on the treatment. Attempting to decrease the drug toxicity, Yang et al. study
the multiple target optimal interventions on the AAnetwork. In their study, the dynamics of AAnetwork
is represented by a group of ODE functions based on enzymatic kinetic and the intervention solutions are
obtained by Monte Carlo simulated annealing stimulation.
In this study, we construct a network with 38 nodes and 69 edges (see Fig 4.4) based on the ODE functions
in the AAnetwork model. Enzymes and metabolites are considered as nodes in the network and there are
three types of edges: from reactants to products, from enzymes to products and from metabolites to enzymes.
The edges from metabolites to enzymes represent the inhibition, activation and upregulation to the enzymes.
In the AAnetwork, the concentrations of LTB4 and PGE2 are related to the inflammation and PGI2 and
TXA2 are related to cardiovascular and bleeding side effects. Then states of these four corresponding nodes
are considered as output nodes in VO of the network when applying our proposed method, which takes both
efficiency and safety into consideration. Similar to stage two in [115], that drug target combinations are
selected from nodes PLA2, LTA4H, 5-LOX, PGES, COX-2 and COX-1, we consider these nodes in the set
S.
PGF2a
9-KPR
PGE2
CR
COX-2
COX-1
TXB2
15-LOX
PGES
15-PGDH
15-keto-PGF2a
15-HETE
6-keto-PGF1a
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12-HETE5-HETE12-HPETE
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LTB4TXAS 20-OH-LTB4
LTA4H 5-HPETELTA4PGDS
PGJ2TXA2
Figure 4.4: AAnetwork. The nodes represented by circles correspond to metabolites and the nodes
represented by round rectangles correspond to enzymes in the AAnetwork. The tinted round rectangle
nodes make up the set VO which represents the outputs of the network. The tinted circle nodes make
up the set S.
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The proposed algorithm finds that a steering node set consisting of 5-LOX and PGES make the network
output controllable and the corresponding GDSC is 20, which is in agreement with the knowledge that
5-LOX is a standard drug target. The identified potential drug target combination by our algorithm is not
the unique set that satisfies the output controllability. Therefore we verify whether the 23 sets of drug target
combinations identified by Yang et al. can make the network system output controllable. We find that 21 sets
of their results satisfied the output controllability requirement, which supports that our proposed method
can give a preliminary view of the potential drug targets.
In addition, drugs such as Aspirin, Celecoxib and Vioxx which target at COX-1 and COX-2 can not
make the AAnetwork output controllable. In fact, these drugs are considered to be lack of efficiency or
will cause cardiovascular or bleeding problems. The drug Licofelone, which target at 5-LOX, COX-1 and
COX-2 can make the AAnetwork output controllable, is an effective anti-inflammation drug without causing
cardiovascular or bleeding problems. The GDCS of selecting 5-LOX, COX-1 and COX-2 as drug targets is 25,
which is larger than the GDCS of selecting 5-LOX and PGES. In fact, PGES converts PGH2 to PGE2 which
is functionally coupled with COX-2. PGE2 is also important for the formation of cytosolic enzyme which is
functionally coupled with COX-1 and COX-2 [152]. So the drug targets of 5-LOX and PGES identified by
the proposed method can provide a reasonable suggestion for the future drug development research.
4.3.2 Results from H.sapiens pathways from KEGG
KEGG (Kyoto Encyclopedia of Genes and Genomes) is a database resource that deal with genomes, biological
pathways, diseases, drugs, and chemical substances [153]. When applying our method to these metabolic
pathways, we consider both metabolites and enzymes as nodes in the constructed networks and select drug
targets from the nodes representing enzymes.
hsa00340: Severity of Parkinson disease is affected by the level of pros-methylimidazoleacetic acid in
the histidine metabolism network (hsa00340). Rasagiline mesylate (D02562), which targets on monoamine
oxidase, is used as an anti-parkinsonian drug. Two studies [15, 154] are on drug target identification and
the biological significance of their methods has been verified by the experiments on this histidine metabolism
network. To verify our proposed method, we choose methylimidazoleacetic acid and methylimidazole ac-
etaldehyde as the output of the system, which is the same as the experiments in [15, 154]. We have found
that the optimal drug target is monoamine oxidase which is the identical to the results in [15, 154]. If a struc-
tural system is structural controllable, almost all numerical systems which have the same structure as the
structural system are controllable [20, 24]. This fact can explain our result by only using network structure
is the same as those in [15, 154].
hsa00230: Febuxostat (D01206) is a drug used to treat hyperuricemia by inhibiting xanthine dehydroge-
nase (EC:1.17.1.4) and xanthine oxidase (EC:1.17.3.2). Excess of urate will lead to hyperuricemia. We have
applied our algorithm to the related metabolic pathway purine metabolism network (hsa00230) and defined
the state of urate as the system output. We find that enzyme EC:2.4.2.16 is the optimal drug target based
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on our model, which is different from the existing drug of febuxostat and the result from Li et al. [15]. Li
et al. suggest that the drug target set consists of three enzymes which are EC:1.17.1.4, EC:1.17.3.2 and
EC:2.4.2.16 and urate can be affected by all these enzymes. However, according to our model, we consider
that by controlling only one of these three enzymes we can control the state of urate. Choosing EC:2.4.2.16
can achieve the smallest GDCS, which means its side effect is minimum. In fact, choosing EC:1.17.1.4 and
EC:1.17.3.2 as targets will not only lead to a large controllable subspace, but also affect many other unrelated
compounds in the network comparing to choosing EC:2.4.2.16, which means much more side effects.
4.4 Conclusion
Identifying drug targets is a major challenge in new drug development where both drug efficiency and safety
should be taken into consideration. Previous network based approaches have made some achievements in
researches of diseases. In this study, we apply the concepts in complex network control to the drug identi-
fication problem. Based on these concepts, we are able to define the measurements of drug efficiency and
its side effects. On the basis of the measurements, we design an algorithm to identify the drug targets. Our
proposed method can also be used to verify the performance of existing drugs as well as find multiple drug
combinations for a certain disease by checking whether the targets of existing drugs can make the biomolecu-
lar networks output controllable. Compared with other network based methods, our approach does not need
the exact values of parameters in a network which are always unknown or hardly to be estimated accurately.
In fact, our method only requires the structure of the biomolecular networks and its results are based on a
general property which is the controllability of complex networks. Indeed, by applying our method to some
real biomolecular networks, one can see our results are supported by existing research results.
In this study, the algorithm is designed to find the minimum number of steering nodes while it does not
focus on GDCS. The future study will make a balance between finding a small set of steering nodes and
making corresponding GDCS small. In addition, we will study the controllability of biomolecular networks
with specific biological information or constraints added to the networks. The drug target identification will
base on the controllability of biomolecular networks instead of general complex networks.
4.5 Appendix
Proof: the number of nodes q matched to nodes in VU ′ in a maximum weight complete matching is minimum.
By contradictory. Assume the score of a maximum weight matching is f + g × ε, where f and g are
integers and g ∗ ε < 1. In the constructed bipartite graph, the score of a complete matching is the sum of
all the weights of edges matched to the nodes in VR. For vsi ∈ VO(i = 1, ..., k), the weights of edges wrsiu′i
between rsi ∈ VR and u′i ∈ V ′U in the bipartite graph are ε×rccsi , which can be considered as 1+ε×rccsi−1.
Then every node vi ∈ VO contributes a weight with integer part 1 to the matching score and every node in
V ′U which has been matched contributes a weight with integer part −1, which suggests f = p− q.
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If q nodes in VR have matched the nodes in V
′
U in the bipartite graph, the score of the maximum weight
matching is
(p− q) + g × ε.
If there is a maximum weight matching that has fewer nodes in VR match nodes in V
′
U , we denote the
number of nodes as q− q′, where q′ is a positive integer number. The score of the maximum-weight matching
will be in form of
(p− q + q′) + g′ ∗ ε,
where g′ × ε < 1.
This score is obviously larger than f + g× ε, which contradicts with the fact that f + g× ε is the score of
a maximum matching. So q is the minimum number of matched nodes in VU ′ in a maximum weight complete
matching.
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ing information
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In previous chapter, we investigated the output controllability of biomolecular networks, which considers
controllability of subsets of nodes from a view of practical application. Besides the interests of controlling
subsets of nodes in networks, other realistic issues should be considered in controlling biomolecular networks.
Guaranteeing controllability is the first step for actually controlling a network. After identifying the steering
nodes by the proposed algorithms, the following procedure can determine the input control signals which
are going to be applied to the steering nodes. To actuate nodes in biomolecular networks, the input control
signals are usually chemical molecules such as drugs. However, it is possible that no drugs can actuate the
identified steering nodes. Since the steering node sets guaranteeing the controllability of networks are not
unique, a method is required to identify specific steering node sets in biomolecular networks such that the
steering nodes have more opportunities to bind to drugs.
In this chapter, an algorithm is developed to identify an MSS with pre-defined preference such that the
preference values of nodes in the identified MSS is the highest among all possible MSSs of the network. To
identify steering nodes with drug binding preference, three schemes to determine preference values of nodes
based on their ability to bind to drugs are compared. Applications to the intracellular signal transduction
network and the colitis-associated colon cancer (CAC) network show that the identified steering nodes are
more likely to be known drug targets and likely to bind to more drugs. This chapter accomplishes Objective
4 of this thesis.
Abstract
Complex networks are ubiquitous in nature. In biological systems, biomolecules interact with each other
to form biomolecular networks, which determine the cellular behaviors of living organisms. Controlling the
cellular behaviors by regulating certain biomolecules in the network is one of the most important problems
in systems biology. Recently, the connections between biological networks and structural control theory have
been explored, uncovering some interesting biological phenomena. Some researchers have paid attention to
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the structural controllability of networks in the context of the minimum steering sets (MSSs). However,
because the MSSs for complex networks are not unique and the importance of different MSSs is diverse in
real applications, MSSs with certain meanings should be studied. In this study, we investigate the MSSs of
biomolecular networks by considering drug binding information. The biomolecules in the MSSs with binding
preference are enriched with known drug targets and are likely to have more chemical-binding opportunities
with existing drugs compared with randomly chosen MSSs, suggesting novel applications for drug target
identification and drug repositioning.
5.1 Introduction
Biomolecules do not perform their functions in isolation. Diverse cellular behaviors of living organisms
are the results of complicated interactions between different biomolecules. The last decade has witnessed
an exceptional development of high throughput technologies, which pave the ways to the reconstruction of
different types of biomolecular networks, such as gene regulatory networks, signal transduction networks
and metabolic networks [155]. Because of the interactions among biomolecules in a biomolecular network,
perturbing some biomolecules can affect others, which may cause the state transition of the whole network and
finally change the cellular behavior. Therefore, controlling the biomolecular networks becomes an attractive
research topic.
To control the biomolecular networks, the prerequisite is the modeling of the dynamics of biomolecular
networks. Several dynamic models have been applied to investigate the dynamics of biomolecular networks
[15, 16, 115, 156, 157]. Based on the kinetics in biochemistry, Yang et al. [115] constructed an arachidonic
acid metabolic network (AAnetwork). The dynamics of the AAnetwork was expressed by the Michaelis-
Menten equations. In their study, the authors both identified the optimal drug targets for anti-inflammation
drugs and found the mechanisms of the side effects of existing drugs NSAIDs and Vioxx. Zhang et al. [156]
proposed a p53 signaling network model and discovered a new mechanism for p53 dynamics and cell fate
decision. Besides biochemical kinetics, Boolean dynamics is also widely used to describe the dynamics of
biomolecular networks. Helikar et al. [157] supposed that the intracellular signaling transduction networks
can be considered as information processing networks. To verify this hypothesis, they created a large scale
network of human cell with logical mechanism of each node and concluded that the intracellular signaling
transduction networks had the characteristics of nontrivial decision-making systems. Flux balance analysis
[158], which is mostly used in metabolic networks, provides another perspective to represent the dynamics of
biomolecular networks. Based on the flux balance analysis, several methods were developed to identify drug
targets in metabolic networks [15, 16].
Many recent studies have focused on the controllability of biomolecular networks based on the linear dy-
namic model, producing interesting results [56, 62, 70, 87, 100, 102, 103]. For example, Wu et al. [56] studied
the structural transittability of complex networks and identified the steering kernels for transiting phenotypes
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of regulatory biomolecular networks. Wu et al. [70] proposed a method for drug target identification based
on the output controllability of biomolecular networks. Some studies have investigated the controllability of
biomolecular networks in the notion of the minimum driver node sets (MDSs) [19]. Badhwar recently et al.
[87] investigated the phenotypic properties and the genetic correlations of the neurons which act as driver
nodes in neuronal network of C.elegans. Vinayagam et al. [103] classified the proteins in the directed human
PPI network as indispensable, dispensable or neutral, which correlate to increasing, no effect, or decreasing
the cardinality of the MDS of the network by removing the proteins and edges that connect to the proteins.
They found that the indispensable proteins in the human PPI network are enriched in human virus targets
and drug targets, both of which provide a novel connection between the network control properties and the
biological observations. However, applying independent control signals on the MDSs is a necessary condition,
but not a sufficient condition, for completely structurally controlling networks. Therefore, Wu et al. [62]
developed an algorithm to identify the minimum steering sets (MSS) of networks and compared the MSSs
and MDSs of several biomolecular networks. An MSS is a minimum set of nodes required to be actuated by
input control signals to have a network structurally controllable.
Studies of MDSs and MSSs provide promising insights for exploring biomolecular networks. However,
since the MDSs or MSSs of a network are not unique, the algorithms for identifying MSSs or MDSs do
not result in a unique set of MSS or MDS. To address this problem, Jia et al. classified a node as critical,
intermittent or redundant if it acts as a driver node in all, some or none of all MDSs, respectively [159]. In
related research, Jia et al. proposed a concept called control capacity, which quantifies the likelihood that a
node is a driver node in an arbitrary MDS [101]. Based on this idea, Liu et al. classified the metabolites in
a human liver metabolic network [102] and calculated the control capacities of proteins in a human signaling
network [100]. Liu’s studies investigated the roles of metabolites in different categories and the proteins with
different control capacities.
In this study, we consider the problem of the non-uniqueness of MSSs from a practical perspective: that
is, to find the MSS of biomolecular networks that should have the most chemical-binding opportunities with
existing drugs. To address this issue, we take the drug binding information into consideration. Specifically
we propose a method to identify the MSSs of biomolecular networks with binding preference such that the
biomolecules in identified MSSs are approved drug targets or have the strong ability to bind to existing
drugs. Actually, the investigation of MSSs with binding preference can be viewed as a network control
problem under constraints in realistic applications. The proposed method can be used to study the control
of biomolecular networks by considering both network dynamics and practical applications, which provides
a novel perspective to explore biomolecular networks.
The rest of this paper is organized as follows: Section II introduces some basic concepts of structural
controllability and presents the algorithm for identifying an MSS with drug binding information. The ma-
terials and the schemes for determining the preference values are also proposed in this section. Section III
illustrates two applications on the intracellular signal transduction network and the Colitis-associated colon
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cancer (CAC) network. Finally, Section IV concludes this study and points out some directions for future
work.
5.2 Methods and materials
In this section, an algorithm is proposed to identify the MSS of a network with steering node preference
after some basic concepts and results are introduced. Nodes in the MSS identified by the proposed algorithm
have the maximum average preference value compared to nodes in other possible MSSs of the network. The
preference values of nodes are defined based on the applications. In this section, the materials that used to
determine the preference values based on drug-protein interactions are also introduced.
5.2.1 Network dynamic model and structural controllability
In this study, we describe the dynamics of a biomolecular network by the linear time-invariant nodal dynamic
model, which can be described by the following equation:
x˙(t) = Ax(t) +Bu(t) (5.1)
where x(t) = (x1(t), ..., xn(t))
T
is a state vector that describes the states of nodes in the biomolecular
network. For biomolecular networks, states of nodes can be concentrations of metabolites or enzymes in a
metabolic network or can be expression levels of genes in a gene regulatory network. A is an n × n state
transition matrix. Each entry aij (i 6= j) in matrix A indicates the strength of influence from biomolecule j
to biomolecule i in the biomolecular network and aii is the sum of strength of self regulation and intrinsic
dynamics, such as degradation, of node i. u(t) = (u1(t), ..., um(t))
T
is an input vector of m independent
input control signals. From the perspective of the biomolecular networks, the input control signals can be
the stimuli from environment or drugs. The n × m matrix B is an input matrix that indicates the nodes
which are directly actuated by input control signals. The dynamics of a network described by equation (5.1)
is denoted as system (A,B).
Because for most biological systems, it is feasible to qualify whether there is a regulatory relationship
between two biomolecules, but difficult to quantify the strength of regulation, in this study, we consider the
structural controllability of biomolecular networks [20]. System (A,B) is called a structural system when the
entries in matrices (A,B) are either fixed zero or independent parameters.
According to the Kalman’s controllability rank condition, system (A,B) is completely controllable if and
only if the n× nm controllability matrix
C =
[
B AB A2B ... An−1B
]
(5.2)
has full rank of n [34]. A structural system (A,B) is completely structurally controllable if it is possible to
choose the values for the independent entries in matrices A and B such that the Kalman’s controllability
rank condition is satisfied [20].
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To investigate the structural controllability, every system (A,B) has a corresponding graph representation
G(A,B) (See Fig. 5.1). G(A,B) is a digraph which contains a set of nodes VA
⋃
VU , where VA = {v1, ..., vn}
and VU = {u1, ..., um} and a set of edges vj → vi for aij 6= 0 and uj → vi for bij 6= 0. G(A) is a subgraph
of G(A, B) induced by the node set VA. The nodes in VA represent state nodes in the network, which
corresponds to the biomolecules in a biomolecular network. The edges between nodes in VA are indicated by
the state transition matrix A, which correspond to the interactions between biomolecules. The nodes in VU
represent input nodes, which correspond to external inputs to the biomolecular network. Each node ui in VU
of G(A,B) corresponds to the input control signal ui(t) in u(t). Edges from a node ui in VU to nodes in VA
are indicated by the ith column in the input matrix B.
u1
v2v3
v4
v1
u2 𝐴𝐴 = � 0 0 0 0𝑎𝑎21 0 0 0𝑎𝑎31 0 0 00 𝑎𝑎42 0 𝑎𝑎44�  
𝐵𝐵 = �𝑏𝑏11 00 𝑏𝑏220 00 0 � 
a
b
b
Figure 5.1: Graph representation of a system. (a): G(A,B) corresponds to system (A,B). (b): The
state transition matrix and input matrix of the system (A,B).
The graph-theoretic conditions for structural controllability have been developed in previous studies
[20, 120]. Before introducing structural controllability theorem, we introduce two following concepts.
Definition 5.1 (Inaccessibility [20, 62]). A node in VA is called accessible if and only if there exists a
directed paths reaching the node from an input vertex in VU , otherwise the node is inaccessible.
Definition 5.2 (Dilation [20, 62]). The digraph G(A,B) contains a dilation if and only if there is a subset S
of VA such that the cardinality of set T(S) is smaller than the cardinality of set S, where T (S) = {vj |(vj →
vi) ∈ E(G), vi ∈ S} and E(G) is the edge set of G(A,B). The input nodes are not allowed to belong to S but
may belong to T(S).
Theorem 5.1 (Structural controllability theorem [20, 62]). A structural system (A,B) is completely struc-
turally controllable if and only if:
i) the digraph G(A,B) contains no dilation.
ii) no node is inaccessible in VA.
5.2.2 Algorithm for identifying MSS with steering node preference
If each node of an MSS is actuated by an independent input control signal, the resulting system G(A,B) is
completely structurally controllable because both conditions i) and ii) of Theorem 5.1 are satisfied. In this
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study, we develop an algorithm to identify an MSS with steering node preference of a network represented
by its structure matrix A. The average of preference values of nodes in the identified MSS is the maximum
among all possible MSSs of the network.
We formulate the identification of the MSS with steering node preference as a minimum cost maximum
flow problem [124] in a corresponding network Gf of a given G(A) with n nodes. To construct the network
Gf, firstly we divide G(A) into strongly connected components (SCCs) [125]. By contracting each SCC to
a single node, the resulting graph is a directed acyclic graph. The SCCs that correspond to nodes without
any incoming edge in the resulting graph are called source SCCs. Then we normalize the preference values of
nodes to the range between 0 to 1. The normalized preference values are denoted as {PV1, · · · , PVn}. Then
Gf can be constructed in the following steps:
1. Construct a bipartite graph which contains node sets R = {r1, · · · , rn} and C = {c1, · · · , cn}. Nodes
ri and ci correspond to the node i of G(A). Connect rj and ci if there is a directed edge from node i
to node j in G(A). The capacity and cost of all these edges in this bipartite graph are one and zero,
respectively.
2. Add a sink node t to the bipartite graph and add edges from all nodes in C to the sink node. The
capacity and cost of all these edges are one and zero, respectively.
3. Add a source node s to the bipartite graph.
4. Let SCC1, SCC2, ..., denote different source SCCs of G(A). For each SCCi that consists of more than
one node, denoting its nodes as SCCi 1, · · · , SCCi j (j > 1):
(a) Create two auxiliary nodes aSCCi 1 and aSCCi 2.
(b) Add an edge from the source to aSCCi 1 with the capacity and cost of the edge being one and
zero, respectively. Add an edge from aSCCi 1 to aSCCi 2 with the capacity and cost of the edge
being one and n −max{PVSCCi 1, · · · , PVSCCi j}, respectively. Add an edge from the source to
aSCCi 2 with the capacity and cost of the edge being j − 1 and zero, respectively.
(c) Add edges from aSCCi 2 to each node of {rSCCi 1, · · · , rSCCi j} with the capacity and cost of the
edges being one and PVSCCi k, k = 1, . . . , j, respectively.
5. For each source SCCi that consists of only one node SCCi 1, add an edge from the source node to
rSCCi1 with the capacity and cost of the edge being one and n, respectively.
6. For non-source SCCi that consists of node SCCi 1, · · · , SCCi j, add edges from the source node to
each node of {rSCCi 1, · · · , rSCCi j} with the capacity and cost of the edges being one and PVSCCi k, k =
1, . . . , j, respectively.
Then the MSS with preference can be determined based on the following theorem [74]:
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Theorem 5.2. For the minimum cost maximum flow f in Gf, the MSS of the network with steering node
preference consists of two types of nodes:
i) nodes in network whose corresponding nodes in R of Gf without the flow f passing through.
ii) If a source SCCi whose all corresponding nodes in R have flow passing through, choose a node in
SCCi with the maximum preference value as a steering node.
Fig. 5.2 is an illustrative example of identifying the MSS with preference. The network has 4 possible
sets of MSSs. The sum of preference values of nodes in the MSS {v3, v4} identified by the method is the
maximum compared to other MSSs (See Table 5.1).
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Figure 5.2: Identification of MSS with the maximum preference values. (a): A network G(A) and its
corresponding transition matrix A. (b): Considering the preference, the minimum cost of maximum
flow in the corresponding Gf of G(A). The labels represent (flow / capacity; cost) of the edges. The
preference values of nodes v1 to v6 are 0.05, 0.1, 0.15, 0, 0.05 and 0, respectively. The red edges
indicate the minimum cost maximum flow. The MSS with the maximum preference values is {v3, v4}.
MSS {v1, v4} {v1, v5} {v2, v4} {v3, v4}
Average value 0.025 0.05 0.05 0.075
Table 5.1: All possible MSSs and their average of preference values.
5.2.3 Preference values and materials
Since we focus on controlling biomolecular networks via the binding of chemicals (drugs) to biomolecules
(proteins) in this study, we take the drug-protein binding information into consideration in order to have
the identified steering nodes (proteins) in MSSs to be more feasibly regulated by drugs. We explore three
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different schemes for defining the preference values of proteins based on the drug-protein interactions. Scheme
I is based on whether a protein is a target of approved drugs: the preference value of the protein is 1 if it
is a target of a drug otherwise it is 0. The preference values based on Scheme I ensures that the proteins
in the MSSs with preference are enriched with drug targets. Scheme II is based on the number of drugs
that can bind to the proteins. The preference values of proteins are calculated by the ratio of the number of
drugs that a protein can bind with to the maximum numbers among all proteins under consideration, which
range from 0 to 1. The preference values based on Scheme II ensures that the proteins in the MSSs with the
preference are likely to interact with more drugs, which suggests there are more options when choosing drugs
for a certain control objective. Scheme III is a combination of Scheme I and Scheme II: the preference value
of a protein is the average of preference values based on Scheme I and Scheme II.
For Scheme I, 2,251 approved drugs are retrieved from DrugBank database (https://www.drugbank.ca)
[160]. The proteins which are the targets of the 2,251 drugs are assigned the preference value of 1. For
Scheme II, the drug-protein interaction data are acquired from STITCH database (http://stitch.embl.de)
[161], which collects the confidence of chemical-protein bindings and chemical-chemical bindings. In the
study, the binding information of 8,037,386 small molecule-protein pairs is downloaded from STITCH. To get
the drug-protein binding information, we firstly retrieve PubChem Compound IDs [162] of all 1,652 approved
small molecule drugs from DrugBank. Then we get the binding information of 295,919 drug-protein pairs
from the small molecule-protein pairs based on PubChem Compound IDs of drugs. Note that Scheme II
only considers the small molecule drugs due to the lack of binding data between biotach drugs and proteins.
To get the binding data from STITCH, the protein names are mapped to STITCH protein IDs based on
Uniprot database (http://www.uniprot.org) [163]. From STITCH, the confidence values of drug binding to
a protein ranges from 0 to 1. The larger the confidence value of a drug and a protein, the more possible
the drug binds to the protein. For Scheme II and Scheme III, the number of drugs that each protein can
bind to is defined as the number of drugs whose binding confidence values with the protein are larger than a
certain threshold sT . In the study, we empirically choose 0.95 as the threshold sT , which suggests that the
drug-protein interactions are with high confidence.
5.3 Applications
We investigate the MSSs with chemical binding preference of two regulatory biomolecular networks. We
demonstrate that the proposed method is capable to identify the MSSs of networks such that the steering
nodes in the identified MSSs are more likely to be regulated by existing drugs, which supports the applicability
of the method.
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5.3.1 Intracellular signal transduction network
Intracellular signal transduction is a process that chemical signals transmit from the outside of cells to
cellular systems, such as the nucleus or cytoskeleton, which could generate appropriate responses to those
signals. To study this process, an intracellular signal transduction network is created by Helikar et al. [157],
which consists of 130 nodes and 558 edges (See Fig. 5.3). The majority of nodes represent proteins and the
other nodes represent metabolites in the network. The edges indicate the regulatory relationships between
nodes. In the network, there are three major receptor families, which are receptor tyrosine kinases (RTKs),
G protein-coupled receptors (GPCRs) and Integrins. In addition, proteins in the network such as Akt, Erk,
Rac, Cdc42 and SAPK are related to cell apoptosis, gene transcription, cytoskeletal regulation and stress of
the cell, respectively. Though the model is a nonspecific network and it does not represent any specific cell
type, the nodes and interactions in the network can be found in a wide range of cell types. Therefore, the
network is a general model that is feasible for investigating the common signal transduction in cells.
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Figure 5.3: Intracellular signal transduction network. The nodes represented by circles correspond
to proteins and the nodes represented by rectangles correspond to metabolites in the network. The
drug target proteins are indicated by the blue circles. The red nodes corresponds to the MSS based
on the preference Scheme III.
The cardinality of an MSS of this network is 17, which suggests that to completely control the network,
there are 13.1% of nodes in the network should be actuated by input control signals. To identify biologically
meaningful MSSs, we investigate the MSSs with drug binding preference based on the three schemes that are
defined in the previous section. For each node that represents a group of proteins, we calculate the number
of drugs that can bind to any one protein in the group. In this network, there are 10 nodes having more than
10 binding drugs and 9 of them corresponds to receptor proteins. Because the maximum number of binding
drugs of a node is 109, in order to attenuate the influence of outliers on the normalized preference values,
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we consider the number of drugs that a node can be bound to as 10 if the number is more than 10 for this
network.
The comparison of different MSSs are shown in Table 5.2. The first row indicates the number of steering
proteins in the MSSs which are drug targets. The second row indicates the average number of drugs that
each protein in the MSSs can be bound to. The four columns in Table 5.2 show the number of drug targets
and the average number of drugs that a protein is likely bound to in the MSSs based on Scheme I, Scheme II,
Scheme III and the average of random selections, respectively. The random selection is based on 1000 runs
of the algorithm developed in our previous study [62] for identifying MSS without preference: to get multiple
MSSs for different runs, the nodes are randomly relabeled in each run. The results with Scheme I indicate
that there are at most 11 proteins in the identified MSS can be drug targets while each steering node has
a small number of binding drugs. Compared to the random MSSs, the MSSs with preference Scheme I is
significantly enriched with drug targets. The results with Scheme II indicate that while the number of drug
targets in it are smaller than the MSS with Scheme I, each protein in the identified MSS can be bound by
3.71 drugs averagely, which is significantly larger than the average number that each protein in a random
MSS can interact with. The different results of MSSs with Scheme I and Scheme II suggest that Scheme I
and Scheme II capture different aspects of drug binding preference respectively. Therefore, it is reasonable
to investigate Scheme III, which is a combination of Scheme I and Scheme II. As expected, the MSS with
Scheme III is enriched with both drug targets and interactions with drugs, which satisfies our objective that
the identified MSSs should feasibly be controlled by drugs in real applications.
Scheme I Scheme II Scheme III
Random
selection
Drug targets 11 8 11 4.32
Interactions 2.76 3.94 3.71 1.08
Table 5.2: Interactions between MSSs and drugs. The first row shows the number of proteins which
are targets of approved drugs in the MSSs with different preference scheme. The second row shows
the average number of drugs that each protein in different MSSs likely interacts with.
Proteins in the MSSs with Scheme III are highlighted as red nodes in Fig. 5.3. In this MSS, the alpha-
i R, Palpha-i R, Palpha-s R and Palpha-12 13 R have the highest preference values, which are both GPCRs.
The observation is in agreement the fact that receptor proteins, especially the GPCRs which are the targets
of 50% of drugs, are enriched with drug targets [164, 165]. Therefore, it is reasonable and applicable to
control the network by regulating the receptor proteins. Other proteins in the MSS also play important
roles in regulating the cellular behaviors. For example, RAC-alpha serine/threonine-protein kinase (AKT)
also has the highest preference value in the network. AKT is a critical regulator of many processes such as
metabolism, proliferation, cell survival, growth and angiogenesis [166–168]. In addition, AKT is also also
found to be critical in the tumor development. For example, inhibitors of Akt have been investigated to treat
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cancers such as neuroblastoma [169] and Arsenic trioxide, which is an inducer of AKT, has been used to the
treatment of acute promyelocytic leukemia (APL) [170].
5.3.2 CAC network
It has been discovered that the inflammation and cancer are closely related [171]. To deeply understand
the mechanism of inflammation-associated cancer, Lu et al. constructed a CAC network by integrating the
extracellular microenvironment and intracellular signalling pathways [172], which contains 70 nodes and 154
regulatory interactions. Based on biological functions, the nodes in the networks can be divided into four
groups: extracellular immune microenvironment, inflammatory signalling, cell proliferation and apoptosis.
In the previous application, we show that Scheme III outperforms the other two schemes. Therefore, we
only consider preference with Scheme III in this application. Applying our method to the CAC network,
we identify the MSSs with preference Scheme III, which is supposed to identify the most feasible MSS to
completely control the network. There are 6 steering nodes in the identified MSS. Four steering proteins in
the MSS are drug targets and each protein can interact with 4.17 drugs averagely. We also investigate 1000
randomly chosen MSSs without preference, in which averagely 2.14 steering proteins are drug targets and
the number of small molecule drugs that each steering protein can interact with is 1.87. Compared to the
randomly chosen MSSs, the proteins in the MSS with preference are significantly enriched with drug targets
and interactions to drugs.
The 6 steering proteins are IL6, TNFA, CCL2, CYTC, APC and SOD, out of which IL6, TNFA and
CCL2 are related to the extracellular immune microenvironment, CYTC2 is related to the apoptosis and
APC and SOD are related to the cell proliferaction process. It can be observed that the steering nodes
belong to different function groups, which is consistent with the knowledge that cancer is a complex disease
and drugs should be applied to multiple targets for cancer therapy [173]. In the identified MSS, APC is a
steering nodes that appears in all the possible MSSs of the CAC network. In fact, researchers have discovered
that the colon cancer may be caused by mutations of the APC gene [174], which suggests the importance of
regulating the APC for controlling the CAC network. IL6 is the target of drug Siltuximab, which has been
investigated for the treatment of several types of cancers [175, 176]. CCL2 is an important mediator of the
cell migration and proliferation of prostate cancer [177] and breast cancer [178]. TNFA, which is produced
mainly by macrophages, is a cell death factor [179]. CYTC plays a important role in apoptosis. When CYTC
is released into the cytosol, it would activate caspases, which are responsible for destroying the cell [180].
Though SOD is not a drug target, it can interact with 2 drugs based on STITCH database.
5.4 Conclusion
In this study, we have investigated the controllability of biomolecular networks by combining drug-protein
binding information. A minimum cost maximum flow algorithm has been developed to identify an MSS based
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on the preference. We applied the algorithm to the intracellular signal transduction network and the CAC
network. The biomolecules in the MSSs with binding preference are enriched with known drug targets and
are likely to have more interactions with drugs compared with randomly chosen MSSs with no preference.
In addition, our results are supported by existing research results, which suggests that our proposed method
could be a promising tool for drug target identification and drug repositioning.
In the future work, other control objectives, such as output controllability with binding information, could
be explored. In addition, other meaningful node preference, such as drug specificity, could be considered for
identifying meaningful MSSs of biomolecular networks.
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6 CytoCtrlAnalyser: a Cytoscape app for biomolecu-
lar network controllability analysis
Published as: L. Wu, M. Li, J. Wang, and F.-X Wu, “CytoCtrlAnalyser: a Cytoscape app for biomolecular
network controllability analysis”, Bioinformatics, vol. 34, no. 8, pp. 1428-1430, 2017. Supplementary
Information along with the published paper is included in Section 6.4 - Section 6.6.
Chapter 2 has introduced various methods to investigate controllability of complex networks and Chapters
3, 4 and 5 have proposed three algorithms for identifying steering node sets. These methods have provided
powerful tools for understanding biomolecular networks as well as general complex networks. However, the
developed algorithms are distributed in the literature and there is no easy access for using the algorithms.
In this chapter, a software system called CytoCtrlAnalyser is developed, which integrates nine network
controllability algorithms including ours and others in the literature. A user guide for CytoCtrlAnalyser is
given which introduces the integrated algorithms and presents two applications to biomolecular networks.
This chapter also includes the details of implementation of the algorithms in CytoCtrlAnalyser and basic
knowledge of network controllability theorems. Objective 5 of the thesis is accomplished in this chapter.
Abstract
Summary: Studying the controllability of biomolecular networks can result in profound knowledge about
molecular biological systems. However, there is no comprehensive and easy-to-use platform for analyzing
controllability of biomolecular networks although various algorithms for analyzing complex network con-
trollability have been proposed recently. In this application note, we develop CytoCtrlAnalyser which is a
Cytoscape app to provide a comprehensive platform for analyzing controllability of biomolecular networks.
Nine algorithms have been integrated in CytoCtrlAnalyser. With network topologies and customized control
settings imported into CytoCtrlAnalyser, users can identify the steering nodes which should be actuated
by input control signals for achieving different control objectives as well as investigate the importance of
nodes from different perspectives in the controllability of networks. CytoCtrlAnalyser offers a tool for many
promising applications, such as identification of potential drug targets or biologically important nodes in
biomolecular networks.
Availability and implementation: Freely available for downloading at http://apps.cytoscape.org/
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apps/cytoctrlanalyser.
6.1 Introduction
With development of high throughput technology, methods are proposed to construct biomolecular networks
from omics data [31, 181]. Biomolecular networks are widely used to model, analyze and understand the mech-
anisms of biological processes. However, the ultimate goal is to change the behaviors or states of biomolecular
networks to the desired ones. Recently, Liu et al. [19] firstly investigated the controllability of complex net-
works based on the structural controllability theorem [20]. Since then, several researchers have expanded
the network controllability studies and their methods have been applied to studying biomolecular networks
[56, 62, 67, 70, 74, 92, 100, 103]. Many interesting biological phenomena have been discovered by investigat-
ing the controllability of biomolecular networks, which suggests promising applications for investigating the
dynamics of biological systems in terms of network controllability.
However, algorithms for analyzing network controllability are scattered in literature and thus they are
inconvenient for the researchers to use. Therefore, a comprehensive platform for running existing control-
lability algorithms is beneficial to researchers. Here we integrate nine recently developed algorithms to
establish a comprehensive platform, called CytoCtrlAnalyser, which is a Cytoscape app that enables users
to conveniently analyze various types of controllability of biomolecular networks within the Cytoscape envi-
ronment [28]. We would like to mention that CytoCtrlAnalyser can be applied to other complex networks
although this study mainly focuses on biomolecular networks. To our best knowledge, CytoCtrlAnalyser is
the first platform that offers such comprehensive calculations and integrates algorithms for investigating the
controllability of biomolecular networks (as well as other complex networks).
6.2 Description of CytoCtrlAnalyser
Functions: Based on the Cytoscape environment, CytoCtrlAnalyser provides a user friendly and straight-
forward interface (Fig. 6.1a). CytoCtrlAnalyser integrates nine recently developed algorithms for analyzing
complex network controllability with different objectives (Fig. 6.1b). The developed algorithms investigate
the network controllability from two aspects. On the one hand, some algorithms identify nodes which should
be actuated by control signals for different control objectives. From this aspect, CytoCtrlAnalyser integrates
algorithms for identification of Minimum Driver node Set (MDS) [19], Minimum Steering node Set (MSS)
[62], MSS with preference [74], steering nodes for transittability [56] and steering nodes for output controlla-
bility [67, 70]. On the other hand, several concepts and algorithms are studied to capture the importance of
nodes from various perspectives. CytoCtrlAnalyser implements four algorithms to calculate control centrality
[182], control capacity [101], node classification [103] and probability of each node in a random MSS [92],
respectively. For more details of functions, see Supplementary Information in Subsection 6.4.1.
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Input: All algorithms in CytoCtrlAnalyser require a network as input. In addition, user customized
data of control settings is also required for algorithms of transittability, output controllability and MSS with
preference. For transittability and output controllability, each node should be assigned a Boolean value to
indicate its role (e.g. an output node or not). For MSS with preference, each node should be assigned a
preference value. The network topology and the user customized data can be stored in .txt format and
imported by the standard Cytoscape method (Fig. 6.1c).
Output: The results of algorithms are displayed in the node table panel (Fig. 6.1d). In the node
table panel, each row corresponds to a node in the network. For each algorithm selected by a user, a
corresponding column will be created. The results of MDS, MSS, MSS with preference, transittability and
output controllability are sets of steering nodes, respectively. The steering nodes are assigned true values
while other nodes are assigned false values. The control capacity values, control centrality values, classification
and probability of nodes in a random MSS are displayed in the corresponding columns.
See Supplementary Information in Section 6.5 for implementation of CytoCtrlAnalyser and Section 6.6
for network controllability theorems.
a b c 
d 
Figure 6.1: Overview of CytoCtrlAnalyser. (a): CytoCtrlAnalyser interface in Cytoscape environ-
ment. (b): Algorithms integrated in CytoCtrlAnalyser. (c): Network topology data and customized
input data. (d): Display of results.
6.3 Case studies
To illustrate how CytoCtrlAnalyser can facilitate researchers to investigate the controllability of biomolecular
networks, we presented two case studies where CytoCtrlAnalyser is applicable. Wu et al. [92] investigated
the MSSs of colitis-associated colon cancer (CAC) network. Based on drug binding information, an MSS
with the highest binding opportunity with drugs has been identified. Instead of implementing complicated
algorithm developed in (Wu et al., 2016b) to identify the MSS with preference, researchers could conveniently
get the results through three steps with CytoCtrlAnalyser. The first step is importing the CAC network and
72
preference values to Cytoscape. The second step is to check the checkbox of MSS with preference and indicate
the name of column which stores the preference values of nodes. Third, by simply clicking the Analyze button,
a corresponding column would be created in the node table and nodes in MSS with drug binding preference
would be indicated by check marks. The MSS with drug binding preference identified by CytoCtrlAnalyser
consists of 6 nodes, which are APC, SOD, IL6, TNFA, CCL2 and CYTC. This result is identical to the result
in Wu??s study [92]. For more details of using CytoCtrlAnalyser and biological explanation of the results,
see Supplementary Information in Subsection 6.4.4.
To explore the effect of removing a node to the controllability of networks, Vinayagam et al. [103] classified
nodes as indispensable, dispensable or neutral. Proteins (nodes) in a directed human PPI network have been
investigated based on this classification. With CytoCtrlAnalyser, the classification of nodes can be quickly
done by importing the human PPI network to Cytoscape, checking the node classification checkbox and
clicking the Analyze button. The classification result is consistent with the result in Vinayagam??s study
[103]. See Supplementary Information in Subsection 6.4.4 for more details.
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6.4 User guide
6.4.1 Functions of CytoCtrlAnalyser
The CytoCtrlAnalyser implements algorithms for studying biomolecular network controllability based on nine
recently proposed concepts: Minimum driver node set (MDS) [19], Minimum steering set (MSS) [62], MSS
with preference [74], steering nodes for state transittability [56] and steering nodes for output controllability
[67], control centrality [63], control capacity [101], classification [103] and probability of each node in a
random MSS [92]. The following paragraphs give the descriptions of algorithms that are implemented for
investigating network controllability.
MDS: A network is completely controllable if it can be steered from any initial states to any desired final
states in finite time. The MDS [19] is a minimum set of nodes in the network which should be actuated by
independent control signals such that the “no dilation” condition of structural controllability theorem [62]
(See Section 6.6.2 for detail) for completely controlling a network can be satisfied. Applying independent
control signals to an MDS is a necessary condition for completely controlling a network. In biomolecular
networks, nodes in MDSs play crucial roles in controlling the networks. Biological functions of MDSs have
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been investigated in different biological networks [87, 100]. In addition, concepts such as control capacity
and node classification are defined based on MDSs of networks.
MSS: The MSS [62] is a minimum set of nodes in the network which should be actuated by control signals
such that the network is completely structurally controllable. Compared to the MDS, applying independent
control signals to an MSS is a sufficient and necessary condition for completely controlling a network, which
satisfies all conditions of structural controllability theorem [62]. Examples are given in [62] to compare MDSs
and MSSs of biomolecular networks.
MSS with preference: Since the MSSs of a network are not unique, an algorithm has been developed
to identify an MSS with certain pre-defined preferences. When each node is assigned a preference value, the
algorithm identifies an MSS that has the maximum average preference value among all the possible MSSs of
the network [74]. In [92], MSSs with drug binding preferences have been identified, which suggests a feasible
way to control biomolecular networks as well as novel applications for drug repositioning.
Transittability: In many applications, we do not need to completely control a network, but to steer the
network from one specific state to another specific state. Therefore, the concept of transittability has been
studied [56]. An algorithm has been designed for identifying steering nodes which should be actuated by
control signals such that the network is structurally transittable between these two specific structural states.
Steering nodes for state transittability of biomolecular networks are investigated in [56], suggesting that the
steering nodes play important roles for state transitions of biomolecular networks.
Output controllability: In CytoCtrlAnalyser, users need to define a set of nodes which correspond to
the output. The implemented algorithm can be used to identify the steering nodes which should be actuated
by control signals such any output state of the system can driven to any other output state [67]. In [67, 70],
output controllability has been used to identify potential drug targets in biomolecular networks such that
the states of output nodes can be controlled.
Control centrality: Control centrality of a node equals to the dimension of the controllable subspace
or the size of the controllable subnetwork when a control signal is actuated only on the node [63].
Control capacity: Since the MDSs of a given network is not unique, the control capacity measures the
likelihood of each node appearing in a random MDS [101]. Control capacity values of nodes in a human liver
metabolic network have been studied [102].
Node classification: The MDSs of a network are not unique, but the cardinality of the MDSs are the
same. Therefore, nodes in a network can be classified as indispensable, neutral or dispensable, which correlate
to increasing, no effect, or decreasing the cardinality of the MDS of the network by removing the node and
edges that connect to the node [103]. Biological roles of different types of proteins in a directed PPI network
have been studied in [103].
Probability in an MSS: Similar to the non-uniqueness of MDSs of networks, there are different MSSs
of a same network. This algorithm quantifies the probability of each node appearing in a random MSS [92].
Nodes with higher probabilities in an MSS have been suggested to play more important roles in controlling
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the network. In addition, by using this algorithm, we have been able to compare preference values of a
randomly selected MSS and an MSS selected with preference.
6.4.2 Quick Start
Following is a short quick start for the usage of CytoCtrlAnalyser:
1. Download and install Cytoscape from http://www.cytoscape.org/
2. Start Cytoscape, install the CytoCtrlAnalyser.jar through App Manager (Apps → App Manager →
Install App → Search CytoCtrlAnalyser → Install).
3. Import or open a network.
4. Click Apps → CytoCtrlAnalyser → Open.
5. Choose one or multiple algorithms in CytoCtrlAnalyser interface on control panel.
6. Import customized data if one of the three algorithms (MSS with preference, transittability and output
controllability) is selected. (i) Click File → Import → Table → File... and select the data file. (ii)
Use Cytoscape interface to import the user customized data from file.
7. Click Analyze button.
Three algorithms, which are MSS with preference, transittability and output controllability, require cus-
tomized data of control settings. Each of the three algorithms requires the user to indicate a column in the
node table panel. The data types are listed:
MSS with preference: Each node should be assigned a real positive number as the preference for
selection of MSS. The data type could be either Integer, Long, Float or Double.
Transittability: Each node should be assigned a Boolean value which indicates whether the state of the
node is going to be changed according to the control objective. Nodes with True values could be changed to
any states in finite time while states of nodes with False values would remain unchanged at the end of the
control process.
Output controllability: Each node should be assigned a Boolean value which indicates whether the
node is corresponding to the output of the network. True means the node corresponds to one output of the
network while False means the node is not the output of the network.
6.4.3 Illustrating example
Import network and open CytoCtrlAnalyser
The first step is to import a network to be studied and open CytoCtralAnalyser app. Fig. 6.2 is an example
of a network with 8 nodes and 10 edges and the CytoCtrlAnalyser interface in Cytoscape.
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Figure 6.2: A example network and the CytoCtrlAnalyser interface.
Import customized data
The data should be stored in a table. There are two ways to manage the table which stores the customized
data. The first method is to create data columns in the node table panel by using the Cytoscape interface. The
second method is to import the data from existing files by using the table importing function of Cytoscape.
Multiple file formats are supported, such as .txt, .xlsx and .csv. Following is an introduction for importing
the customized data from files.
1. Click File → Import → Table → File... and select the data file.
2. Import the columns from file. See Fig. 6.3.
To import the customized data, a table file should be created. In Fig. 6.3a, the first column is the names
of nodes in Cytoscape, which is used as the key to map the nodes and node attributes. The second column in
Fig. 6.3a is the preference values of nodes for the MSS identification with preference. For CytoCtrlAnalyser,
the preference values could be any positive numbers. The third column contains Boolean values for nodes,
which is used as the customized data for analysing the network transittability or output controllability. In
Fig. 6.3a, node 4, node 5 and node 6 are set as True. For network transittability, the states of node 4,
node 5 and node 6 could be changed to any values at the end of control process while the states of other
nodes would remain unchanged. For output controllability, the states of node 4, node 5 and node 6 could be
changed to any values at the end of control process while the states of other nodes are not considered in the
output controllability study.
Fig. 6.3b is the interface of importing the table file to Cytoscape. The first column is selected as the key,
which would match the values to corresponding nodes in Cytoscape. Users need to indicate the data types
of different columns: the second column is set as Floating point and the third column is set as Boolean. Fig.
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Key - Integer 
Attribute – Floating Point 
Attribute - Boolean 
a b
c
Figure 6.3: Procedures of importing customized data. (a): An .txt file with preference values and
Boolean values. (b): Interface of Cytoscape for importing the data to the node table panel. (c):
Imported customized data in the node table panel.
6.3c is the data imported to Cytoscape shown in node table panel: Column 2 saves the preference values
of nodes and Column 3 indicates the node whose states are supposed to be changed in state transition or
output control.
Analyse controllability of network
Nine algorithms for network controllability analyses are included in CytoCtrlAnalyser. To apply controllabil-
ity algorithms, users simply need to check the algorithms they would like to use. For the state transittability
and output controllability, the nodes whose states are going to be changed are required to be indicated. For
MSS with preference, the preference value of each node should be input. To indicate the customized data,
the names of columns containing the corresponding data are required to be indicated in the text boxes on
the right of the algorithm check boxes.
Fig. 6.4a is an overall interface of the input and the result display. In the illustrating example, we indicate
Column 2 as the user input data for the MSS with preference algorithm and Column 3 as the user input
data for state transittability and output controllability. Then we check Select all box and press the Analyze
button (See Fig. 6.4b).
The results are displayed in Fig. 6.4c. For the example network, node 4 and node 8 make up one possible
MDS of the network. The control capacity of node 1 to node 8 are 0.374, 0, 0, 0.508, 0, 0.368, 0.358, and
0.392, respectively. The control centrality of node 1 to node 8 are 4, 3, 3, 3, 2, 1, 1 and 2, respectively. For
node classification, node 1, node 4 and node 8 are classified as neutral nodes (labeled as 1); node 2, node
3 and node 5 are indispensable nodes (labeled as 2); node 6 and node 7 are dispensable nodes (labeled as
0). Node 3, node 4 and node 8 make up one MSS of the network. The possibility of node 1 to node 8 that
appear in an MSS are 0.54, 0.223, 0.227, 0.636, 0.364, 0, 0 and 1, respectively. As Column 3 indicated, if we
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CytoCtrlAnalyser interface 
Result display 
a
b
c
Figure 6.4: Procedures of importing customized data. (a): The .txt file which indicates the preference
values for choosing the MSS and the nodes for the transittability or output controllability. (b): The
interface of Cytoscape for importing the data to the node table panel. (c): The imported customized
data shown in the node table panel.
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would like to change the state of node 4, node 5 and node 6 without effecting the states of other nodes, node
4 and node 6 are required to be actuated by control signals. According to the output controllability, if we
would like to change the states of node 4, node 5 and node 6 while not considering the states of other nodes,
it can be achieved by actuating node 4 only. Based on the input preference values, the node 3, node 4 and
node 8 make up the most preferred MSS.
6.4.4 Application examples
MSSs with drug binding preference of colitis-associated colon cancer (CAC) network
In [92], Wu et al. investigated the MSS with drug binding preference of CAC network. This subsection gives
an application example to show how to get the MSS with drug binding preference by using CytoCtrlAnalyser.
1. Acquire the CAC network from paper [172]. The network file is reformed to .txt format which can be
supported by Cytoscape (Fig. 6.5a).
2. Import the CAC network to Cytoscape and open the CytoCtrlAnalyser interface (Fig. 6.5b).
a b
Figure 6.5: CAC network file opened in Cytoscape.
3. Check the Probability in a random MSS checkbox and press Analyze button. After results appear in
node table, sort the table in descending order based on values in column ProbabilityInMSS. We can see
that there are 20 nodes with nonzero values, which means only these 20 nodes can be steering nodes in
MSSs of the CAC network (Fig. 6.6a). The reason is that the other nodes never appear in any MSSs
and their preference values do not impact the result of MSS with preference.
4. Acquire drug binding preference values of 20 nodes identified in step 3 by using the strategy proposed
in [92]. Because nodes CTL, DC, MAC and TREG correspond to different types of cells, which do not
correspond to specific proteins, the preference values of these nodes are set to 0.
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a b c
Figure 6.6: Importing preference values of nodes to Cytoscape.
5. Import the preference values to Cytoscape. In Fig. 6.6b, the first column lists the node names, the
second column indicates whether the node is a target of any approved drugs and the third column shows
to number of drugs that can bind to the node with high confidence according to STITCH database
(http://stitch.embl.de) [161]. The MSS is identified based on the preference values in the forth column,
which are calculated by values in the second and the third columns.
6. Check the checkbox MSS with preference and input PreferenceValues in the following text area (Fig.
6.7a).
7. Press Analyze button and the MSS with preference is indicated in column MSSWithPreference of node
table (Fig. 6.7b).
a b
Figure 6.7: Identifying MSS with preference.
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From Fig. 6.7b, we can see that the MSS with drug binding preference consists of 6 steering nodes
(proteins), which are APC, CCL2, CYTC, SOD, IL6 and TNFA. The result is exactly the same as the result
in [92]. According to analyses in [92], controlling the CAC network by actuating states of the 6 identified
proteins is biologically meaningful. Firstly, these steering nodes belong to three different function groups,
which are cell proliferation process, extracellular immune microenvironment and apoptosis. This observation
is consistent with the knowledge that cancer is a complex disease and drugs should be applied to multiple
targets for cancer therapy [173]. For individual node in the MSS with drug binding preference, APC is a
steering nodes that appears in all the possible MSSs, which suggests the importance of APC in completely
controlling CAC network. Actually, researchers have discovered that the colon cancer may be caused by
mutations of the APC gene [174]. CCL2 is observed as an important mediator of the cell migration and
proliferation of prostate cancer [177] and breast cancer [178]. Drug Siltuximab, which targets at IL6, has
been investigated for the treatment of different cancers [175, 176]. In addition, TNFA is a cell death factor
[179] and CYTC is related to apoptosis.
In the table, we can also find that 4 steering nodes in the MSS are drug targets and each node can
interact with 4.17 drugs averagely. By multiplying corresponding values in column ApprovedDrugTarget and
column ProbabilityInMSS, we can find that averagely there are only 2.19 steering nodes that are targets
of approved drugs in a random MSS without preference. Similarly, by multiplying corresponding values in
column NumOfPossibleDrug and column ProbabilityInMSS, we can find that each steering node in a random
MSS can interact with only 1.84 drugs averagely. The results demonstrate that steering proteins in the MSS
with drug binding preference are significantly enriched with drug targets and interactions to drugs, which
suggests that controlling CAC network by actuating states of steering proteins in the MSS with drug binding
preference is more feasible compared to actuating nodes in a randomly selected MSS.
Node classification of human directed PPI network
Vinayagam et al. [103] classified the proteins in the directed human PPI network as indispensable, neutral
or dispensable, which correlate to increasing, no effect or decreasing the cardinality of MDS of the resulting
network by removing the proteins and edges that connect to proteins.
CytoCtrlAnalyser implements an algorithm to classify nodes based on this classification method. To get
the classification, firstly the directed human PPI network can be acquired from supplementary materials of
reference [4]. Then the network is imported to Cytoscape and CytoCtrlAnalyser is opened. After this, the
classification of nodes can be calculated by checking the Node classification checkbox and pressing the Analyze
button. The result is shown in column Classification of node table panel, in which 0, 1 and 2 correspond to
dispensable, neutral and indispensable, respectively (Fig. 6.8).
To verify the classification result from CytoCtrlAnalyser, we imported the classification of nodes in refer-
ence [103] to column Node Class of node table panel. By comparing the results, we found that for all 6,338
nodes in the network, only classification of protein PRG2 is different. PRG2 is classified as a indispensable
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Figure 6.8: Node classification of human directed PPI network.
node by CytoCtrlAnalyser while [103] suggested it is dispensable. To verify the classification of PRG2, we
used MDS algorithm in CytoCtrlAnalyser to calculate MDS of the network and MDS of resulting network
after the removal of node PRG2, respectively. We found that the cardinalities of MDSs are 2,282 and 2,283,
respectively. Removing node PRG2 from the network increases the cardinality of MSS, which suggests PRG2
is an indispensable node and the classification result from CytoCtrlAnalyser is correct. The reason of ref-
erence [103] has different classification of PRG2 is probably that the PPI network used in [103] is slightly
different from the PPI network in [4]. It is because the network in [103] has 6,339 nodes and 34,813 directed
edges while the network file downloaded from [4] has 6,337 nodes and 34,814 directed edges.
CytoCtrlAnalyser provides a platform for users to get access to different network controllability algo-
rithms. However, biological interpretations of results from CytoCtrlAnalyser depend on specific problems,
which require researchers to analyse the results based on their own knowledge and proposes. In [103], au-
thors found that indispensable proteins in the human PPI network are enriched in human virus targets, drug
targets or disease-causing mutations. Their study provides a fresh classification method based on network
controllability, which shows distinct biological properties in the context of essentiality, conservation and reg-
ulation. Therefore, CytoCtrlAnalyser provides a convenient tool for future studies on different biomolecular
networks based on the classification method.
82
6.5 App implementation
6.5.1 CytoCtrlAnalyser architecture
CytoCtrlAnalyser is a Cytoscape app that is implemented based on the Open Service Gateway Initiative
(OSGi) framework. OSGi is a Java framework for developing and deploying modular software programs and
libraries. The recent versions of Cytoscape platform has adopted OSGi technology [183]. Therefore, both
core modules and Apps in Cytoscape 3.x are OSGi bundles, which reduces the complexity of developing
Apps remarkably. In addition, Cytoscape is a software developed in Java. Therefore, Cytoscape takes the
advantage of Java that can be run in different operating systems with the Java virtual machine (JVM). The
relationships among CytoCtrlAnalyser, Cytoscape and their running environments are shown in Fig. 6.9.
Cytoscape (3.0+)
OSGi
Bundles
Core Modules App (CytoCtrlAnalyser)
JVM (Java virtual machine)
Operating System(Windows/ MacOS/ Linux)
Figure 6.9: Relationships among the CytoCtrlAnalyser, Cytoscape and their running environments.
To achieve the functions of CytoCtrlAnalyser, there are three main functions modules in the CytoCtrl-
Analyser, which are listed below.
1. Interface module: After opening CytoCtrlAnalyser, only one panel is created, which is the CytoCtrl-
Analyser control panel. Users are able to check the checkbox to select the controllability algorithms
they would like to run on the network loaded in Cytoscape. After pressing the Analyze button, the
results are shown in the node table of table panel.
2. Task manage module: This module has two functions. The first is to receive the instructions from
Cytoscape and open / close the CytoCtrlAnalyser control panel. Second, the module monitors action
of the Analyze button on the control panel and calls algorithms accordingly.
3. Algorithm module: There are two parts in this module. The first part includes a group of algorithms
related to the network control. Since the network control problems are formulated as graph-theoretic
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problems, the second part includes several classical algorithms in graph theorem which are called by
the controllability algorithms.
6.5.2 Relationships among the controllability algorithms
There are nine network controllability algorithms implemented in CytoCtrlAnalyser. The relationships among
these algorithms can be represented by Fig. 6.10.
MDS
MSS
MSS with 
preference
State transition
Output control
Control capacity
Control centrality
Classification
Completely control networks
Identify steering nodes to be 
actuated by control signals
Other control objectives
Evaluate Individual 
node importance
Node probability in a 
random MSS
Figure 6.10: Relationships among network controllability algorithms.
From Fig. 6.10 we can see that the algorithms for MDS, MSS, MSS with preference, output controllability
and state transittability are designed to identify a set of nodes which should be actuated by control signals
such that different control objectives could be achieved. The algorithms for control capacity, control centrality,
node classification and node probability in random MSS are designed to evaluate the importance of nodes
from different aspects in the controllability of networks. Besides algorithms for output controllability and
state transittability, all the algorithms are designed based on the completely controllability of networks. The
arrows from MDS to MSS and from MSS to MSS with preference indicate the progress of the research on
network controllability. Controlling an MDS is a necessary condition for completely controlling a network.
To further investigate the controllability, the MSS has been proposed, which is a sufficient and necessary
condition for completely controlling a network. Since MSSs of a network are not unique, the MSS with
preference has been studied.
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To investigated the controllability of networks, the studies have formulated the problems in control theory
to the graph theoretic problems based on the structural control theorem. Therefore, nine network control-
lability algorithms are implemented based on classical graph-theoretic algorithms. The relationships among
the network controllability algorithms and graph-theoretic algorithms are illustrated in Fig. 6.11.
5
Control Algorithms
MDS
Classical Algorithms
Maximum weight 
complete matching
Minimum cost 
maximum flow
MSS
MSS with preference
State transition
Output control
Control centrality
Control capacity
Maximum matching
Find strongly 
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Find Subnetworks
DijsktraNode classification
Node probability in 
random MSS
Figure 6.11: Calling relationship of algorithms.
6.5.3 Algorithm implementation
Since most algorithms are illustrated comprehensively in the related papers [19, 56, 62, 63, 67, 70, 74, 101, 103],
this section only gives brief explanations for some specific problems during implementation.
When running the algorithms, CytoCtrlAnalyser acquires network information from Cytoscape and create
a copy of the network, which is stored in the form of adjacent list. Therefore, all graph-theoretic algorithms
are implemented based on the adjacent list in CytoCtrlAnalyser, which would enable the controllability
algorithms to run on large networks and have higher efficiency for sparse networks.
MDS
The identification of MDS can be formulated as a maximum cardinality bipartite matching problem in a
bipartite graph corresponding to the original network. The detail about the MDS and the identification
algorithm can be referred in [19]. In CytoCtrlAnalyser, Hopcroft?CKarp algorithm [71] is employed to solve
the maximum cardinality matching problem.
It should be mentioned that the MDSs of a network are not unique. For the algorithm of identifying MDS,
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there are no stochastic variables when CytoCtrlAnalyser copies the network from Cytoscape and identifies
the MDS. Therefore, for a given network imported to Cytoscape, the CytoCtrlAnalyser always returns a
same MDS. In addition, it should be noticed that the identified MDSs of a network is related to the node
order or edge order in the adjacent list created by CytoCtrlAnalyser. If a network is input with different
orders of nodes or edges, CytoCtrlAnalyser may identifies different MDSs of the network.
MSS and MSS with preference
The identification of MSS has been formulated to a minimum cost maximum flow (MCMF) problem in a
digraph which is constructed according to the topology of the network. The detail of the algorithm can
be referred in [62] and the algorithm for solving the MCMF problem can be found in [73]. Notice that
for each MSS, there is a subset of the MSS being an MDS. Then we firstly identify an MDS to improve
the algorithm efficiency during the implementation of the algorithm. The identified MDS corresponds to a
zero cost flow in the constructed digraph and the final MCMF could be augmented from the zero cost flow.
Similar to the identification of MDS, there are no stochastic variables when CytoCtrlAnalyser retrieves the
network from Cytoscape and identifies the MSS. Therefore, for a given network imported to Cytoscape, the
CytoCtrlAnalyser always returns a same MSS. If different MSSs are needed, the network with different orders
of nodes or edges should be input to CytoCtrlAnalyser.
The digraph constructed for the identification of MSS can also be applied to identify MSS with preference.
However, to identify MSS with preference, costs of some edges in the digraph should be modified according to
the preference values of nodes. The MCMF in the modified digraph indicates the MSS with preference. The
detailed description of the algorithm can be referred in [92]. In CytoCtrlAnalyser, the users need to indicate
the column which stores the preference values of nodes in the node table. It is possible that more than one
MSSs in a network have the same maximum preference value. In this situation, CytoCtrlAnalyser always
returns a same MSS with maximum preference. If different MSSs with maximum preference are needed, the
network should be input to CytoCtrlAnalyser with different orders of nodes or edges.
Transittability and output controllability
Both the algorithms for transittability and output controllability require the users to indicate a column
in node table with Boolean values. The nodes whose states are intended to be changed by the users are
assigned true values. The difference between investigating the structural transittablilty and structural output
controllability is that when steering the states of selected nodes, the structural transittablilty does not change
the states of other nodes while output controllability does not consider the states of other nodes.
The identification of steering nodes for transittability and output controllability have been formulated
to maximum weight complete matching problem in two different bipartite graphs constructed according to
network topology and customized control settings. In CytoCtrlAnalyser, the maximum weight complete
matching problem is solved by the Kuhn-Munkres (KM) algorithm [81]. Detail description of constructing
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the weighted bipartite graph for transittability and output controllability can be referred in [56] and [70],
respectively.
Control capacity and probabilities of nodes in a random MSS
Both MDSs and MSSs of a network are not unique. Therefore, to understand the roles of nodes played
in controllability of networks, it is worthwhile studying the probabilities that the nodes would appear in a
random MDS / MSS. Control capacity is to MDSs of networks as probability in an MSS is to MSSs.
The control capacity measures the likelihood of each node appearing in a random MDS. The algorithm
to calculate the control capacity can be referred in [101]. The algorithm iterates many times to randomly
sample MDSs of a network. Each iteration identifies one MDS and the MDSs identified by different iterations
could be identical. Then the likelihood is the ratio of the times that a node appearing in MDSs to the times
of iterations. In [101], the authors claimed that by iterating T = NlnN times, where N is the number of
nodes in the network, the sampling results converge to the actual values. However, when N is small, the
number of iterations could not take enough samples of MDSs and the results do not converge to the actual
values. Therefore, for the implementation of the algorithm, the value T is defined as Max(NlnN, 1000),
which is the larger value between NlnN and 1000.
For the calculation of nodes’ probabilities in a random MSS, there is no algorithm developed to sample
MSSs uniformly at present. CytoCtrlAnalyser implements a method proposed in [92] to sample MSSs of
networks. To sample different MSSs, the algorithm in CytoCtrlAnalyser intentionally exchanges the orders
of nodes or edges when retrieving network topology from Cytoscape. The algorithm would return different
MSSs since the orders of nodes or edges are different. Due to the efficiency and running time, the method
samples 1000 MSSs at each execution.
Control centrality
Control centrality is developed to quantify the ability of a node to control a network, which equals to the
dimension of the controllable subspace. In other words, by regulating only one node with control signal, the
maximum number of nodes whose states can be steered from any initial state to any final state in the network
is equal to the control centrality of the node. The CytoCtrlAnalyser integrates the algorithm to calculate
the control centrality that is proposed in [63].
Node classification
The MDSs of a network are not unique, but the cardinality of the MDSs are the same. Based on the effect
of removing a node to the cardinality of the MDSs, the paper [103] classified the nodes as indispensable,
neutral or dispensable, which correlate to increasing, no effect, or decreasing the cardinality of the MDSs of
the network by removing the node and edges that connect to the node.
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6.6 Network dynamic model and structural controllability theo-
rems
6.6.1 System dynamic model and graph representation
In CytoCtrlAnalyser, all implemented algorithms are based on networks with linear dynamics. Although
dynamics of biological systems are nonlinear, the controllability of nonlinear systems is in many aspects
structurally similar to that of linear systems. First, investigating controllability of locally linearized system
is the first step to ultimately develop control strategies for complex nonlinear networks [40]. In addition,
if a network is structurally controllable, then it is completely controllable for almost all possible parameter
realizations [20]. Therefore, the structural controllability of linear system can provide a sufficient condition
for controllability for most nonlinear systems [19, 51]. Recently, by applying structural linear controllability
theorems to nonlinear C. elegans neuron network, researchers predicted the involvement of each C. elegans
neuron in locomotor behaviors and then verified their prediction by experiments [94], which provided a
directly experimental proof of the feasibility of developed structural controllability theorems.
In this study, the dynamics of a network with n nodes is represented by the linear time-invariant dynamic
model, which is described by the equation:
x˙(t) = Ax(t) +Bu(t), (6.1)
where x(t) = (x1(t), ..., xn(t))
T
is a state vector that describes the states of all the nodes in the network. A
is an n × n state transition matrix, which is determined by the adjacent matrix of the network, indicating
the regulatory relationships between nodes in the network. u(t) is an input vector of m independent input
control signals. The n×m matrix B is an input matrix that indicates the nodes which are directly actuated
by input control signals. The network with the control signals described by the equation (6.1) is denoted as
system (A,B).
Each system (A,B) has a corresponding graph representation G(A,B) (See Fig. 6.12). G(A,B) is a
digraph which contains nodes VA = {v1, ..., vn} and VU = {u1, ..., um} as well as edges vj → vi for aij 6= 0
and uj → vi for bij 6= 0. The original network without input control signals is denoted as G(A), which is a
subgraph of G(A, B) induced by the node set VA, where nodes in VA correspond to the nodes in the original
network. The edges between nodes in VA are indicated by the state transition matrix A, which indicate the
regulatory interactions between nodes. The nodes in VU represent input nodes, which correspond to external
control signals or environmental stimuli to the network. Each node ui in VU of G(A,B) corresponds to the
entry ui(t) in u(t). Edges from a node ui in VU to nodes in VA are indicated by the ith column in the input
matrix B. Fig. 6.12 is an example of the system (A,B) and its graph representation.
For many real complex networks, such as biomolecular networks, it is feasible to qualify whether there
is a regulatory relationship between two nodes (biomolecules), but it is difficult to quantify the strength of
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Figure 6.12: Graph representation of system (A,B). (a): G(A,B) corresponds to system (A,B).
(b): The state transition matrix and input matrix of the system (A,B).
the regulation. Therefore, the concept of the structural system has been applied to study the dynamics of
network systems [20]. System (A,B) is called a structural system when the entries in matrices (A,B) are
either fixed zero or independent parameters. The following subsections give some introduction to the control
problems based on structural systems.
6.6.2 Completely structural controllability
A network is completely controllable if it can be steered from any initial state x0 to any desired final state
x1 in finite time with appropriate control signals. According to the Kalman’s controllability rank condition,
system (A,B) is completely controllable if and only if the n× nm controllability matrix
C =
[
B AB A2B ... An−1B
]
(6.2)
has full row rank n [34]. For structural systems, we say the structural system (A,B) is completely structurally
controllable if it is possible to choose the values for the independent entries in matrices A and B such that
the Kalman’s controllability rank condition is satisfied [20].
The graph-theoretic conditions for structural controllability have been developed in previous studies
[20, 120]. Before introducing structural controllability theorem, we introduce two following concepts.
Definition 6.1 (Inaccessibility [20, 62]). A node vi in the digraph G(A,B) is called inaccessible if and only
if there exist no directed paths reaching vi from an input vertex in VU .
Definition 6.2 (Dilation [20, 62]). The digraph G(A,B) contains a dilation if and only if there is a subset
S of VA such that |T (S)| < |S|, where T (S) = {vj |(vj → vi) ∈ E(G), vi ∈ S} and E(G) is the edge set of
G(A,B). |S| and |T (S)| are the cardinality of set S are T(S), respectively.
Theorem 6.1 (Structural controllability theorem [20, 62]). A structural system (A,B) is completely struc-
turally controllable if and only if:
i) no dilation in digraph G(A,B).
ii) no inaccessible node in VA.
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6.6.3 Structural output controllability
The output of a linear dynamic system (A,B) can be described by the following equation:
y(t) = Cx(t) (6.3)
where y(t) = (y1(t), ..., yp(t))
T
is an output vector of the network and each entry represents an output. The
outputs of the network are linear combinations of node states in the network represented by the p×n matrix
C. A system described by equations (6.1) and (6.3) is denoted by matrix triplet (A,B,C).
In this study, the outputs of a network is defined as states of a set of nodes. Based on this definition of
output, there is one and only one nonzero entry in each row of C and the nonzero entry indicates one node
in the network as an output. Then y(t) is a p-dimensional vector that each entry corresponds to state of one
node. By defining the outputs in this way, the output controllability is basically the same as the concept of
target controllability [68].
A system is output controllable if for any initial output vector y0 = y(t0) and any other final output
vector y1, there exists a finite time tf and inputs u(t), such that y(tf ) = y1. For a system (A,B,C), the
p×mn output controllability matrix is defined as:
oC =
[
CB CAB CA2B ... CAn−1B
]
. (6.4)
Based on the control theory, system (A,B,C) is output controllable if and only if rank (oC) = p [69].
For structural systems, by arbitrarily choosing the value of free parameters in A, B and C, the rank of
oC can reach a maximum value. The maximum value is defined as the generic dimension of the controllable
output subspace of structural system (A,B,C) and denoted by GDCOS(A,B,C) [24, 70]. The structural
system (A,B,C) is structurally output controllable if GDCOS(A,B,C) = p.
6.6.4 Structural transittability
If there exists input control signals u(t), t ∈ [0, tf ], by which the system (A,B) can be transited between
two specific states x0 and x1. The system (A,B) is called transittable between these two specific states.
For structural matrix M, if a matrix M˜ can be obtained by fixing the independent entries of M at some
specific values, the matrix M˜ is called admissible with respect to M. Considering a structural system (A,B),
the state vector x is a structural vector, in which entries are independent parameters or fixed zeros. A
structural system (A,B) is called structural transittable between two structural states x0 and x1 if and only
if there exist matrices A˜, B˜, x˜0 and x˜1 which are admissible with respect to A, B, x0 and x1, respectively,
such that the system (A˜, B˜) is transittable between x˜0 and x˜1 [56].
For structural system (A,B), by arbitrarily choosing the value of free parameters in A and B, the rank of
controllability matrix C can reach a maximum value, which is denoted as generic dimension of controllable
subspace GDCS(A,B). Then we have the following theorem for structural transittability:
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Theorem 6.2. (Structural transittability theorem) [56] The structure system (A,B) is structurally transit-
table between two specific structural states x0 and x1 with either belonging to span{C}, if and only if
GDCS(A, B¯) = GDCS(A,B),
where B¯ = [x0 − x1, B].
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7 Summary, contributions and future work
7.1 Summary
In order to control states of complex networks, the first challenge is to identify the minimum set of steering
nodes which should be actuated by input control signals. For biomolecular networks, the difficulties come
from the lack of accurate dynamic models and methods for analysing the controllability of dynamic models.
Recent progress on the controllability of general complex networks have been made based on structural
controllability theorems. To better understand the controllability of biomolecular networks, this thesis aims
to identify the minimum set of steering nodes in different scenarios of controlling biomolecular networks. In
addition, a software system which integrates controllability algorithms is implemented.
Chapter 2 provides a comprehensive review of network controllability and achieves Objective 1. It summa-
rizes methods to investigate controllability of complex networks and the applications to biological networks.
For different methods, the motivations and the application scenarios are discussed.
Chapter 3 studies the minimum number of steering nodes required to completely control complex networks.
The minimum steering node set is denoted as MSS. By comparing the biological significance of the MSSs
and the MDSs, which is a commonly used concept in network controllability studies, we conclude that MSSs
are more critical in the dynamics of biomolecular networks. Objective 2 is accomplished by Chapter 3.
Chapter 4 and Chapter 5 fulfil Objective 3 and Objective 4, respectively. Objective 3 and Objective 4
are motivated by realistic demands or constraints on the steering nodes. On one hand, Objective 3 aims
at improving the efficiency of control by using fewer steering nodes to achieve control objectives. Based on
this idea, an algorithm is proposed to identify steering nodes for output controllability of complex networks
in Chapter 4. Output controllability measures the ability of controlling the states of subsets of nodes in
networks by actuating the steering nodes. Compared to completely controlling a whole network, controlling
subsets of nodes in the network requires fewer steering nodes, which is more efficient. On the other hand,
for controlling biomolecular networks, chemical molecules such as drugs are the most feasible types of input
control signals. Since not all biomolecules have the same chance to be actuated by available drugs, Objective
4 intends to increase the likelihood that the identified steering nodes can be actuated by available drugs.
Chapter 5 fulfills this objective by developing an algorithm to identify steering nodes with preference. When
preference values are assigned to nodes according to their abilities to bind to drugs, the developed algorithm
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can identify a steering node set which is most likely to be actuated by drugs as input control signals.
Chapter 6 introduces a software system called CytoCtrlAnalyser. CytoCtrlAnalyser is a Cytoscape app
for analysing controllability of complex networks. Nine network controllability algorithms for: identification
of (1) MDS [19], (2) MSS [62], (3) MSS with preference [74], (4) steering nodes for transittability [56] and (5)
steering nodes for output controllability [67, 70], and calculation of (6) control centrality [182], (7) control
capacity [101], (8) node classification [103] and (9) probability of each node in a random MSS [92], are
integrated in the current version of CytoCtrlAnalyser.
7.2 Future work
Based on the work presented in the thesis, some directions of future work are proposed as follows:
1. Identifying steering nodes sets with drug binding preference for different control objectives.
In the thesis, an algorithm was developed to identify an MSS based on certain pre-defined preferences.
Since the MSS is one type of steering node set for complete controllability and there are other types
of steering node sets for different control objectives such as output controllability and transittability,
algorithms to identify steering node sets with preference for different control objectives are needed.
For example, the output controllability can be applied to the drug target identification in biomolecular
networks and the identified steering nodes are considered as potential drug targets. If the steering node
sets are identified based on the drug binding preference, the potential drug targets are more likely to
be actuated by available drugs.
2. Extending structural controllability theorems for better dynamic models of biomolecular networks.
The thesis studies controllability of biomolecular networks based on structural controllability theorems.
However, biomolecular networks show some properties that make directly using structural controllabil-
ity theorems inappropriate. For example, structural controllability makes a general assumption that all
the nonzero entries in state transition matrices of biomolecular networks are independent. However, reg-
ulatory interactions between biomolecules may depend on each other, which suggests that the nonzero
entries in state transition matrices may not be independent. Thus algorithms should be developed to
study the controllability of networks with dependent nonzero entries in state transition matrices.
3. Considering trajectories of control processes.
Some states of the biomolecular networks may be lethal for the biomolecular systems. When steering
biomolecular networks from certain states to other desired states, the trajectories of transition processes
should avoid these forbidden states. Therefore, methods should be developed to determine control
strategies to avoid some forbidden states in state transition trajectories and to find optimal steering
node sets based on the strategies.
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4. Investigating observability of biomolecular networks.
Observability is a mathematical dual problem of controllability, which measures the ability of inferring
states of nodes in a network by monitoring the states of some nodes in the network. Since there is much
similarity between controllability and observability mathematically, the methods developed for network
controllability can be extend to network observability. By observing states of a specific set of nodes,
the states of other nodes or the whole network can be inferred, which suggests promising applications
such as disease diagnosis and early disease detection.
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